TW201431860A - Method for production of 1,2-dihydroquinoline synthetic intermediate - Google Patents

Method for production of 1,2-dihydroquinoline synthetic intermediate Download PDF

Info

Publication number
TW201431860A
TW201431860A TW102147141A TW102147141A TW201431860A TW 201431860 A TW201431860 A TW 201431860A TW 102147141 A TW102147141 A TW 102147141A TW 102147141 A TW102147141 A TW 102147141A TW 201431860 A TW201431860 A TW 201431860A
Authority
TW
Taiwan
Prior art keywords
group
salt
formula
compound represented
acid
Prior art date
Application number
TW102147141A
Other languages
Chinese (zh)
Inventor
大野敦嗣
工藤一弘
勝平健
Original Assignee
參天製藥股份有限公司
協和發酵生化股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 參天製藥股份有限公司, 協和發酵生化股份有限公司 filed Critical 參天製藥股份有限公司
Publication of TW201431860A publication Critical patent/TW201431860A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

Abstract

Provided is a method for production of a compound represented by formula (2), or a salt thereof, which is characterized in enabling a compound represented by formula (1) or a salt thereof to react with 2, 2-dialkoxy propane or isopropenyl alkyl ether in the presence of (A) acid selected from the group consisting of p-toluene sulfonic acid, p- toluene sulfonic acid pyridinium, hydrobromic acid and pyridine hydrobromide and/or (B) base selected from the group consisting of pyridine and N, N-dimethylaniline, and (C) water. The method of this invention is suitable for the industrial production of a synthetic intermediate for dihydroquinoline derivative having glucocorticoid receptor binding activity.

Description

1,2-二氫喹啉合成中間體之製造方法 Method for producing 1,2-dihydroquinoline synthesis intermediate

本發明係有關具有糖皮質激素受容體結合活性的1,2-二氫喹啉衍生物之合成中間體的製造方法。 The present invention relates to a process for producing a synthetic intermediate of a 1,2-dihydroquinoline derivative having a glucocorticoid receptor-binding activity.

以式(2)表示的化合物或其鹽係已知可使用來作為例如具有糖皮質激素受容體結合活性的1,2-二氫喹啉衍生物之合成中間體(專利文獻1)。合成上述式(2)表示的化合物或其鹽之方法,在專利文獻1中係記載著使用如下反應之合成方法:以8-胺基-3-羥基苯并[c]苯并吡喃(chromene)-6-酮作為原料,而使用碘及丙酮,形成1,2-二氫喹啉骨架。於該方法的後處理中必須以管柱層析儀的精製步驟(以下,亦稱為管柱精製),故在工業上製造仍有問題。因此,嘗試在上述反應後,不進行管柱精製而使式(2)表示的化合物或其鹽之酚性羥基進行對-甲氧基苯甲基化或苯甲基氧基甲基化,以製造式(3)表示的化合物或其鹽,但因在反應系中殘留碘,故產生副 反應,以致難以有效率地製造式(3)表示的化合物或其鹽。 The compound represented by the formula (2) or a salt thereof is known as a synthetic intermediate which can be used as, for example, a 1,2-dihydroquinoline derivative having a glucocorticoid receptor-binding activity (Patent Document 1). A method of synthesizing the compound represented by the above formula (2) or a salt thereof, and Patent Document 1 describes a synthesis method using the following reaction: 8-amino-3-hydroxybenzo[c]benzopyran (chromene) The 6-ketone is used as a raw material, and iodine and acetone are used to form a 1,2-dihydroquinoline skeleton. In the post-treatment of the method, it is necessary to carry out the purification step of the column chromatography (hereinafter also referred to as column purification), so that there are still problems in industrial production. Therefore, after the above reaction, the phenolic hydroxyl group of the compound represented by the formula (2) or a salt thereof is subjected to p-methoxybenzylation or benzyloxymethylation without performing column purification. The compound represented by the formula (3) or a salt thereof is produced. However, since iodine remains in the reaction system, a side reaction occurs, so that it is difficult to efficiently produce the compound represented by the formula (3) or a salt thereof.

[式(3)中,R0表示對-甲氧基苯甲基或苯甲基氧基甲基。] [In the formula (3), R 0 represents p-methoxybenzyl or benzyloxymethyl. ]

[先前技術文獻] [Previous Technical Literature]

[專利文獻] [Patent Literature]

[專利文獻1]國際公開2008/059865號小冊 [Patent Document 1] International Publication No. 2008/059865

本發明的目的在於發現一種適合於工業上製造具有糖皮質激素受容體結合活性的1,2-二氫喹啉衍生物之合成中間體的新穎製造方法。 SUMMARY OF THE INVENTION An object of the present invention is to find a novel production method suitable for industrially producing a synthetic intermediate of a 1,2-dihydroquinoline derivative having a glucocorticoid receptor-binding activity.

有鑑於此種實情,本發明人深入探討的結果,發現藉由使具有羥基的8-胺基-苯并[c]苯并吡喃-6-酮衍生物在特定的酸及/或鹼、及水的存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應,不使用碘而可獲得1,2-二氫喹啉衍生物的合成中間體之式(2)表示的化合物或其鹽。並且,該反應後,不須管柱精製,使式(2)表示的化合物或其鹽之酚性羥基進行對-甲氧基苯甲基化或苯甲基氧基甲基化,可不須管柱精製而可有效率地獲得式(3)表示的化合物或其鹽。 In view of such facts, the inventors have intensively studied and found that by using an 8-amino-benzo[c]benzopyran-6-one derivative having a hydroxyl group in a specific acid and/or base, In the presence of water, it is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether, and the synthetic intermediate of the 1,2-dihydroquinoline derivative can be obtained without using iodine (2). A compound or a salt thereof. Further, after the reaction, the phenolic hydroxyl group of the compound represented by the formula (2) or a salt thereof can be subjected to p-methoxybenzylation or benzyloxymethylation without the need for column purification. The column is purified to efficiently obtain a compound represented by the formula (3) or a salt thereof.

同時,也發現式(2)表示的化合物或其鹽可由式(4)表示的化合物或其鹽獲得。 Meanwhile, it has also been found that the compound represented by the formula (2) or a salt thereof can be obtained from the compound represented by the formula (4) or a salt thereof.

並且發現,藉由以對-甲苯磺酸、鹽酸或溴酸處理式(5)表示的化合物或其鹽,可獲得過濾性佳的式(1)表示之化合物的對-甲苯磺酸鹽、鹽酸鹽或溴酸鹽,而完成本發明。 Further, it has been found that by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfonate and a salt of the compound represented by the formula (1) excellent in filterability can be obtained. The present invention has been accomplished by acid or bromate.

亦即,本發明係如以下所述之發明。 That is, the present invention is as described below.

[1]一種式(2)表示的化合物或其鹽之製造方法, 其特徵係使式(1)表示的化合物或其鹽在 (A)選自對-甲苯磺酸、對-甲苯磺酸吡啶鎓、溴化氫酸及吡啶溴化氫酸鹽所形成之群組中的酸及/或(B)選自吡啶及N,N-二甲基苯胺所形成之群組中的鹼、及(C)水的存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應。 [1] A method for producing a compound represented by the formula (2) or a salt thereof, Characterized by the compound represented by the formula (1) or a salt thereof (A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrogen bromide and pyridine hydrobromide and/or (B) selected from the group consisting of pyridine and N, The base in the group formed by N-dimethylaniline and (C) water are reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether.

[2]一種式(3)表示的化合物或其鹽之製造方法, [式中,R0表示對-甲氧基苯甲基或苯甲基氧基甲基。],其特徵係藉由上述[1]的方法,獲得式(2)表示的化合物或其鹽,接著使該式(2)表示的化合物或其鹽在選自酸及鹼所形成之群組中的至少一種之存在下,與式(a)R0X表示的化合物或其鹽反應。 [式中,R0表示對-甲氧基苯甲基或苯甲基氧基甲基,X表示脫離基。] [2] A method for producing a compound represented by the formula (3) or a salt thereof, [wherein, R 0 represents p-methoxybenzyl or benzyloxymethyl. The compound represented by the formula (2) or a salt thereof is obtained by the method of the above [1], and then the compound represented by the formula (2) or a salt thereof is selected from the group consisting of an acid and a base. In the presence of at least one of them, it is reacted with a compound represented by the formula (a) R 0 X or a salt thereof. Wherein R 0 represents p-methoxybenzyl or benzyloxymethyl, and X represents a leaving group. ]

[3]如上述[1]或[2]之製造方法,其中,由上述[1]之式(1)表示的化合物或其鹽製造式(2)表示的化合物或其鹽之反應,為經由反應中途生成的式(4)表示之化合物或其鹽而進行。 [3] The method for producing the compound represented by the formula (2) or a salt thereof, the compound represented by the formula (1) of the above formula (1) or a salt thereof, is a reaction method according to the above [1] or [2] The compound represented by the formula (4) or a salt thereof formed in the middle of the reaction is carried out.

[4]如上述[1]至[3]之製造方法,其中,式(1)表示的化合物或其鹽為使式(5)表示的化合物或其鹽與對-甲苯磺酸、鹽酸或溴酸反應所製造的。 [4] The production method of the above [1] to [3], wherein the compound represented by the formula (1) or a salt thereof is a compound represented by the formula (5) or a salt thereof and p-toluenesulfonic acid, hydrochloric acid or bromine Manufactured by acid reaction.

[5]如上述[1]至[4]之製造方法,其中,式(1)表示的化合物之鹽為式(1)表示的化合物之對-甲苯磺酸鹽、鹽酸鹽或溴酸鹽。 [5] The production method of the compound of the above formula (1), wherein the salt of the compound represented by the formula (1) is a p-toluenesulfonate, a hydrochloride or a bromate of the compound represented by the formula (1). .

[6]一種式(7)表示的化合物或其鹽之製造方法, [式中,R1表示鹵素原子、低級烷基、羥基、低級烷氧基、低級烷基羰基、羧基、胺基、硝基或氰基;p表示0至4的整數。],其係使式(6)表示的化合物或其鹽在 [式中,R1表示鹵素原子、低級烷基、羥基、低級烷氧基、低級烷基羰基、羧基、胺基、硝基或氰基;p表示0至4的整數。](A)選自對-甲苯磺酸、對-甲苯磺酸吡啶鎓、溴化氫酸及吡啶溴化氫酸鹽所形成之群組中的酸及/或(B)選自吡啶及N,N-二甲基苯胺所形成之群組中的鹼、及(C)水的存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應。 [6] A method for producing a compound represented by the formula (7) or a salt thereof, [wherein, R 1 represents a halogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amine group, a nitro group or a cyano group; and p represents an integer of 0 to 4. ], which is a compound represented by the formula (6) or a salt thereof [wherein, R 1 represents a halogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amine group, a nitro group or a cyano group; and p represents an integer of 0 to 4. (A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrogen bromide and pyridine hydrobromide and/or (B) selected from the group consisting of pyridine and N The reaction with a 2,2-dialkoxypropane or an isopropenylalkyl ether in the presence of a base in the group formed by N-dimethylaniline and (C) water.

[7]如上述[1]至[6]的製造方法,其中,2,2-二烷氧基丙烷為2,2-二甲氧基丙烷。 [7] The production method according to the above [1] to [6] wherein the 2,2-dialkoxypropane is 2,2-dimethoxypropane.

[8]如上述[1]至[6]的製造方法,其中,異丙烯基烷基醚為異丙烯基甲基醚。 [8] The production method according to the above [1] to [6] wherein the isopropenylalkyl ether is isopropenylmethyl ether.

[9]一種化合物及其鹽,其係選自‧8-胺基-3-羥基苯并[c]苯并吡喃-6-酮的對-甲苯磺酸鹽、‧8-(1,1-二甲基-3-側氧基丁基胺基)-3-羥基苯并[c]苯并吡喃-6-酮、‧8-胺基-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮、 ‧8-胺基-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮、‧8-(1,1-二甲基-3-側氧基丁基胺基)-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮、‧8-(1,1-二甲基-3-側氧基丁基胺基)-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮、‧2-(2,4-二甲氧基苯基)-5-胺基苯甲酸甲酯、‧6-(2,4-甲氧基)-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯、‧6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸、‧6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯、‧2-溴-5-(1,1-二甲基-3-側氧基丁基胺基)苯甲酸甲酯。 [9] A compound and a salt thereof, which are selected from p-toluenesulfonate of ‧8-amino-3-hydroxybenzo[c]benzopyran-6-one, ‧8-(1,1 - dimethyl-3-oxobutylbutylamino)-3-hydroxybenzo[c]benzopyran-6-one, ‧8-amino-3-(4-methoxybenzyl Oxy)benzo[c]benzopyran-6-one, ‧8-Amino-3-benzyloxymethoxybenzo[c]benzopyran-6-one, ‧8-(1,1-dimethyl-3-oxobutylbutylamine 3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one, ‧8-(1,1-dimethyl-3-oxobutyl Amino)-3-benzyloxymethoxybenzo[c]benzopyran-6-one, ‧2-(2,4-dimethoxyphenyl)-5-aminobenzoic acid Methyl ester, methyl ‧6-(2,4-methoxy)-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylate, ‧6-bromo-2,2 ,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid, ‧6-bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid Ester, methyl ‧ 2-bromo-5-(1,1-dimethyl-3-oxobutylbutylamino)benzoate.

依照本發明,藉由使具有羥基的8-胺基-苯并[c]苯并吡喃-6-酮衍生物在酸及/或鹼、及水的存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應,不使用碘而可獲得1,2-二氫喹啉衍生物的合成中間體之式(2)表示的化合物或其鹽。同時,在該反應後,不須管柱精製,使式(2)表示的化合物或其鹽之酚性羥基進行對-甲氧基苯甲基化或苯甲基氧基甲基化,則不須管柱精製而可有效率地獲得式(3)表示的化合物或其鹽。同時,式(2)表示的化合物或其鹽係可由式(4)表示的化合物或其鹽獲得。並且,藉由以對-甲苯磺酸、鹽酸或溴酸處理式(5)表示的化合物或其鹽,可獲得過濾性佳的式(1)表示之化合物的對-甲苯磺酸鹽、鹽酸鹽或溴酸鹽。 According to the present invention, by reacting an 8-amino-benzo[c]benzopyran-6-one derivative having a hydroxyl group with 2,2-dioxane in the presence of an acid and/or a base, and water The compound represented by the formula (2) or a salt thereof can be obtained by reacting oxypropane or isopropenyl alkyl ether without using iodine to obtain a synthetic intermediate of the 1,2-dihydroquinoline derivative. At the same time, after the reaction, the phenolic hydroxyl group of the compound represented by the formula (2) or the salt thereof is subjected to p-methoxybenzylation or benzyloxymethylation without the column purification. The compound represented by the formula (3) or a salt thereof can be efficiently obtained by purifying the column. Meanwhile, the compound represented by the formula (2) or a salt thereof can be obtained from the compound represented by the formula (4) or a salt thereof. Further, by treating the compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid, p-toluenesulfonate and hydrochloric acid of the compound represented by the formula (1) excellent in filterability can be obtained. Salt or bromate.

以下詳細說明本說明書中所使用的原子、基、環等之定義。同時,以下詞語之定義準用於另一詞語之定義時,也可準用於各定義較佳的範圍及特佳的範圍。 The definitions of atoms, radicals, rings, and the like used in the present specification are described in detail below. At the same time, when the definition of the following words is used in the definition of another word, it can also be used in the preferred range and the particularly good range of each definition.

「鹵素原子」表示氟原子、氯原子、溴原子或碘原子。 The "halogen atom" means a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.

「低級烷基」表示碳原子數1至8個的直鏈或分枝之烷基,宜為1至6個碳原子數,而以1至4個碳原子數尤佳。具體例,可舉出甲基、乙基、正丙基、正丁基、正戊基、正己基、正庚基、正辛基、異丙基、異丁基、第二丁基、第三丁基、異戊基等。 The "lower alkyl group" means a linear or branched alkyl group having 1 to 8 carbon atoms, preferably 1 to 6 carbon atoms, and particularly preferably 1 to 4 carbon atoms. Specific examples thereof include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, isopropyl group, isobutyl group, second butyl group, and third group. Butyl, isopentyl and the like.

「低級烷氧基」表示羥基的氫原子經低級烷基取代之基。具體例,可舉出甲氧基、乙氧基、正丙氧基、正丁氧基、正戊氧基、正己氧基、正庚氧基、正辛氧基、異丙氧基、異丁氧基、第二丁氧基、第三丁氧基或異戊氧基等。 The "lower alkoxy group" means a group in which a hydrogen atom of a hydroxyl group is substituted with a lower alkyl group. Specific examples thereof include a methoxy group, an ethoxy group, a n-propoxy group, a n-butoxy group, a n-pentyloxy group, a n-hexyloxy group, a n-heptyloxy group, a n-octyloxy group, an isopropoxy group, and an isobutyl group. An oxy group, a second butoxy group, a third butoxy group or an isopentyloxy group.

「低級烷基羰基」表示甲醯基的氫原子經低級烷基取代之基。具體例,可舉出甲基羰基、乙基羰基、正丙基羰基、正丁基羰基、正戊基羰基、正己基羰基、異丙基羰基、異丁基羰基、第二丁基羰基、第三丁基羰基或異戊基羰基等。 The "lower alkylcarbonyl group" means a group in which a hydrogen atom of a formazan group is substituted with a lower alkyl group. Specific examples thereof include a methylcarbonyl group, an ethylcarbonyl group, a n-propylcarbonyl group, a n-butylcarbonyl group, a n-pentylcarbonyl group, a n-hexylcarbonyl group, an isopropylcarbonyl group, an isobutylcarbonyl group, a second butylcarbonyl group, and a Tributylcarbonyl or isopentylcarbonyl and the like.

「胺基」可舉出-NH2基或經1或2個的低級烷基取代之胺基等。 The "amino group" may, for example, be an -NH 2 group or an amine group substituted with 1 or 2 lower alkyl groups.

「脫離基」表示可藉由反應而脫離的取代基。具體例,可舉出氟原子、氯原子、溴原子、碘原子等鹵素原子、甲烷磺醯基氧基、氯甲基亞碸基氧基、三氟甲烷磺醯基氧基等低級烷基磺醯基氧基、苯磺醯基氧基、對-甲苯磺醯基氧基等芳基磺醯基氧基、氰基、硝基、三氯乙醯亞胺酯等。 "Dissociation group" means a substituent which can be detached by a reaction. Specific examples thereof include a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, a lower alkyl sulfonate such as a methanesulfonyloxy group, a chloromethylphosphoniumoxy group or a trifluoromethanesulfonyloxy group. An arylsulfonyloxy group such as a mercaptooxy group, a phenylsulfonyloxy group or a p-toluenesulfonyloxy group; a cyano group, a nitro group, a trichloroacetonitrile imine ester or the like.

本發明中使用的原料、試藥、其他本案說明書中所述之化合 物,也可形成酸或鹼與「鹽」。具體例,可舉出鹽酸、溴化氫酸、溴酸、碘化氫酸、硝酸、硫酸、磷酸等無機酸與鹽、碳酸、醋酸、反丁烯二酸、順丁烯二酸、琥珀酸、檸檬酸、酒石酸、己二酸、葡萄糖酸、葡庚糖酸、葡萄糖醛酸、對苯二甲酸、甲烷磺酸、乳酸、馬尿酸、1,2-乙烷二磺酸、羥乙基磺酸、乳糖酸、油酸、帕莫酸、聚半乳糖醛酸、硬脂酸、丹寧酸、三氟甲烷磺酸、苯磺酸、對-甲苯磺酸、10-樟腦磺酸、硫酸十二烷酯、硫酸甲酯、萘磺酸、磺基水楊酸等有機酸與鹽、甲基溴、甲基碘等四級銨鹽、溴離子、氯離子、碘離子等鹵素離子與鹽、鋰、鈉、鉀等鹼金屬與鹽、鈣、鎂等鹼土金屬與鹽、銅、鐵、鋅等之金屬鹽、銨與鹽、三伸乙基二胺、2-胺基乙醇、2,2-亞胺基雙(乙醇)、1-去氧基-1-(甲基胺基)-2-D-山梨醇、2-胺基-2-(羥基甲基)-1,3-丙二醇、普魯卡因、N,N-二甲基苯胺或N,N-雙(苯基甲基)-1,2-乙烷二胺等有機胺與鹽、吡啶與鹽等。 Raw materials, reagents, and other combinations described in the present specification used in the present invention It can also form acids or bases and "salts". Specific examples thereof include inorganic acids and salts such as hydrochloric acid, hydrogen bromide acid, bromic acid, hydrogen iodide acid, nitric acid, sulfuric acid, and phosphoric acid, carbonic acid, acetic acid, fumaric acid, maleic acid, and succinic acid. , citric acid, tartaric acid, adipic acid, gluconic acid, glucoheptonic acid, glucuronic acid, terephthalic acid, methanesulfonic acid, lactic acid, hippuric acid, 1,2-ethanedisulfonic acid, hydroxyethylsulfonate Acid, lactobionic acid, oleic acid, palmitic acid, polygalacturonic acid, stearic acid, tannic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, 10-camphorsulfonic acid, sulfuric acid Organic acids and salts such as dialkyl ester, methyl sulfate, naphthalenesulfonic acid and sulfosalicylic acid; quaternary ammonium salts such as methyl bromide and methyl iodide; halogen ions and salts such as bromide, chloride and iodide; Alkali metals and salts such as lithium, sodium and potassium, alkaline earth metals and salts such as calcium and magnesium, metal salts such as copper, iron and zinc, ammonium and salts, tri-ethylenediamine, 2-aminoethanol, 2,2 -iminobis(ethanol), 1-desoxy-1-(methylamino)-2-D-sorbitol, 2-amino-2-(hydroxymethyl)-1,3-propanediol, Procaine, N,N-dimethylaniline or N,N-bis(benzene An organic amine such as a methyl group)-1,2-ethanediamine and a salt, a pyridine and a salt.

本發明中使用的原料、試藥、其他本案說明書中所述之化合物,也可為水合物或溶劑合物的形態。 The raw materials, reagents, and other compounds described in the present specification used in the present invention may be in the form of a hydrate or a solvate.

本發明中使用的原料、試藥、其他本案說明書中所述之化合物中存在幾何異構體或光學異構體時,其異構體亦包含在本發明的範圍中。 When a geometric isomer or an optical isomer is present in the starting materials, reagents, and other compounds described in the present specification, the isomers are also included in the scope of the present invention.

本發明中使用的原料、試藥、其他本案說明書中所述之化合物存在質子互變異構時,其互變異構體亦包含在本發明的範圍中。 When a raw material, a reagent, and other compounds described in the present specification have proton tautomerism, the tautomer thereof is also included in the scope of the present invention.

本發明中使用的原料、試藥、其他本案說明書中所述之化合物、此等的水合物或溶劑合物也可為結晶,在該結晶中存在結晶 多形體及結晶多形群(結晶多形系)時,此等的結晶多形體及結晶多形群(結晶多形系)亦包含在本發明中。此處,結晶多形群(結晶多形系),指可藉由此等結晶的製造、晶析、保存等的條件及狀態(又,本狀態中亦包含製劑化的狀態),而使結晶形有各種變化時的各階段中之結晶形及其整體過程。 The raw materials, reagents, other compounds described in the specification, and the hydrates or solvates thereof may also be crystals in the present invention, and crystals are present in the crystals. In the case of polymorphs and crystalline polymorphs (crystalline polymorphs), such crystalline polymorphs and crystalline polymorphs (crystalline polymorphs) are also included in the present invention. Here, the crystal polymorphism (crystal polymorph) refers to a condition and a state in which production, crystallization, storage, and the like can be performed by such crystallography (and, in this state, a state in which formulation is also included), and crystallization is performed. The shape of the crystal in each stage of the change and its overall process.

以下,說明本發明的製造方法。 Hereinafter, the production method of the present invention will be described.

製造方法1 Manufacturing method 1

式(2)表示的化合物或其鹽,可依照以下的步驟1(合成路徑1-1)及步驟2(合成路徑1-2)進行製造。 The compound represented by the formula (2) or a salt thereof can be produced by the following steps 1 (synthesis route 1-1) and step 2 (synthesis route 1-2).

<步驟1> <Step 1>

步驟1是使式(5)表示的化合物或其鹽與對-甲苯磺酸、鹽酸或溴酸反應而製造式(1)表示的化合物或其鹽之步驟。又,式(5)表示的化合物或其鹽,可依照國際公開2012/108455號小冊中之說明而獲得。 Step 1 is a step of producing a compound represented by the formula (1) or a salt thereof by reacting a compound represented by the formula (5) or a salt thereof with p-toluenesulfonic acid, hydrochloric acid or bromic acid. Further, the compound represented by the formula (5) or a salt thereof can be obtained according to the description in the International Publication No. 2012/108455.

相對於式(5)表示的化合物或其鹽,對-甲苯磺酸、鹽酸或溴酸可使用0.1等量以上,並以使用1至6等量為佳,而以使用3至4等量更佳。 With respect to the compound represented by the formula (5) or a salt thereof, p-toluenesulfonic acid, hydrochloric acid or bromic acid may be used in an amount of 0.1 or more, and preferably 1 to 6 is used, and 3 to 4 is used. good.

此步驟中使用的溶劑,只要不阻礙反應,可為某程度溶解起始物質的溶劑,無特別的限定,可列舉:例如苯、甲苯、二甲苯等芳香族烴類;二氯甲烷、氯仿、四氯化碳、二氯乙烷、 氯苯、二氯苯等鹵化烴類;二乙基醚、二異丙基醚、四氫呋喃、環戊基甲基醚、甲基-第三丁基醚、二烷、二甲氧基乙烷、二乙二醇二甲基醚等醚類;醋酸乙酯、醋酸異丙酯等羧酸低級烷酯類;甲醯胺、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-四氫吡咯酮、六甲基磷三醯胺等醯胺類;二甲基亞碸、環丁碸等亞碸類;甲醇、乙醇、丙醇、異丙醇、丁醇、異丁醇、第三丁醇等低級醇類;水;或此等溶劑之混合溶劑,並以低級醇類與水為佳,而以乙醇與水更佳。 The solvent to be used in this step is not particularly limited as long as it does not inhibit the reaction, and examples thereof include aromatic hydrocarbons such as benzene, toluene, and xylene; dichloromethane, chloroform, and the like. Halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether, two Ethers such as alkane, dimethoxyethane, diethylene glycol dimethyl ether; lower alkyl carboxylic acids such as ethyl acetate and isopropyl acetate; formamide, N,N-dimethylformamidine Amidoxime such as amine, N,N-dimethylacetamide, N-methyl-2-tetrahydropyrrolidone, hexamethylphosphoric acid triamide, etc.; anthraquinones such as dimethyl hydrazine and cyclobutyl hydrazine; a lower alcohol such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol or tert-butanol; water; or a mixed solvent of such solvents, and preferably a lower alcohol and water, Ethanol and water are better.

反應溫度雖然可依原料化合物、反應試藥而異,但可在0℃至100℃進行,並以0℃至50℃為佳。 Although the reaction temperature may vary depending on the starting compound and the reaction reagent, it may be carried out at 0 ° C to 100 ° C, preferably 0 ° C to 50 ° C.

反應時間雖然可依反應溫度、原料化合物、反應試藥或使用的溶劑種類而異,但一般是1分鐘至48小時,並以15小時至24小時為佳。 The reaction time may vary depending on the reaction temperature, the starting compound, the reaction reagent or the solvent to be used, but it is usually from 1 minute to 48 hours, and preferably from 15 hours to 24 hours.

反應完畢後,使反應液放冷,一邊在冰冷下攪拌,一邊添加水、氨水、甲醇等溶劑,將析出的固體過濾或進行萃取操作,在濃縮後獲得的殘渣中添加甲苯、醋酸乙酯等可再結晶的溶劑後,將析出的固體過濾、乾燥後即可得目的化合物。又,將析出的固體過濾之後,宜以甲苯、醋酸乙酯、水等洗淨。 After the reaction is completed, the reaction solution is allowed to cool, and a solvent such as water, ammonia water or methanol is added thereto while stirring under ice cooling, and the precipitated solid is filtered or subjected to an extraction operation, and toluene, ethyl acetate or the like is added to the residue obtained after concentration. After the solvent which can be recrystallized, the precipitated solid is filtered and dried to obtain the objective compound. Further, after the precipitated solid is filtered, it is preferably washed with toluene, ethyl acetate, water or the like.

必要時,所得的目的化合物可由一般進行的方法精製,例如再結晶、再沉澱等。 When necessary, the obtained objective compound can be purified by a general method such as recrystallization, reprecipitation, or the like.

同時,目的化合物係可形成對-甲苯磺酸鹽、鹽酸鹽或溴酸鹽而得。 At the same time, the compound of interest can be obtained by forming p-toluenesulfonate, hydrochloride or bromate.

<步驟2> <Step 2>

步驟2是製造式(2)表示的化合物及其鹽之製造步驟,其係使式(1)表示的化合物及其鹽在(A)選自對-甲苯磺酸、對-甲苯磺酸吡啶鎓、溴化氫酸及吡啶溴化氫酸鹽所形成之群組中的酸及/或(B)選自吡啶及N,N-二甲基苯胺所形成之群組中的鹼、及(C)水之存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應。<步驟2>的圖中,R2是表示低級烷基,並以甲基為佳。 Step 2 is a production step of producing a compound represented by the formula (2) and a salt thereof, wherein the compound represented by the formula (1) and a salt thereof are selected from (A) selected from the group consisting of p-toluenesulfonic acid and pyridinium p-toluenesulfonate. An acid in the group formed by hydrogen bromide and pyridine hydrobromide and/or (B) a base selected from the group consisting of pyridine and N,N-dimethylaniline, and (C) In the presence of water, it is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether. In the graph of <Step 2>, R 2 represents a lower alkyl group, and a methyl group is preferred.

此步驟中使用的酸(A),以對-甲苯磺酸或對-甲苯磺酸吡啶鎓為佳,並以對-甲苯磺酸更佳。 The acid (A) used in this step is preferably p-toluenesulfonic acid or pyridinium p-toluenesulfonate, and more preferably p-toluenesulfonic acid.

相對於式(1)表示的化合物或其鹽,此步驟中可使用0.10當量以上的酸(A),並以0.5至2.0當量為佳,而以0.90至1.10當量更佳。 With respect to the compound represented by the formula (1) or a salt thereof, 0.10 equivalent or more of the acid (A) may be used in this step, preferably from 0.5 to 2.0 equivalents, more preferably from 0.90 to 1.10 equivalents.

此步驟中使用的鹼(B),宜為吡啶。 The base (B) used in this step is preferably pyridine.

相對於式(1)表示的化合物或其鹽,此步驟中可使用0.10當量以上的鹼(B),並以0.5至2.0當量為佳,而以0.90至1.10當量更佳。 With respect to the compound represented by the formula (1) or a salt thereof, 0.10 equivalent or more of the base (B) may be used in this step, preferably from 0.5 to 2.0 equivalents, more preferably from 0.90 to 1.10 equivalents.

此步驟中,也可使用(A)及(B)。此時,是以使用對-甲苯磺酸作為(A)、吡啶作為(B)的組合為佳。 In this step, (A) and (B) can also be used. In this case, it is preferred to use a combination of p-toluenesulfonic acid as (A) and pyridine as (B).

同時,也可使用(A)或(B)。如使用(A)時,以使用對-甲苯磺酸 吡啶鎓為佳。 At the same time, (A) or (B) can also be used. When using (A), use p-toluenesulfonic acid Pyridinium is preferred.

同時,相對於式(1)表示的化合物或其鹽,此步驟中可使用5當量以上的水(C),並以10至30當量為佳,而以15至25當量更佳。 Meanwhile, with respect to the compound represented by the formula (1) or a salt thereof, 5 equivalents or more of water (C) may be used in this step, preferably 10 to 30 equivalents, and more preferably 15 to 25 equivalents.

同時,此步驟中使用的2,2-二烷氧基丙烷,可列舉:例如2,2-二甲氧基丙烷、2,2-二乙氧基丙烷等,相對於式(1)表示的化合物或其鹽,其可使用10當量以上,並以30至100當量為佳,而以50至60當量更佳。 Meanwhile, examples of the 2,2-dialkoxypropane used in this step include, for example, 2,2-dimethoxypropane, 2,2-diethoxypropane, and the like, with respect to the formula (1). The compound or a salt thereof may be used in an amount of 10 equivalents or more, preferably 30 to 100 equivalents, more preferably 50 to 60 equivalents.

同時,此步驟中使用的異丙烯基烷基醚,可列舉:例如異丙烯基甲基醚、異丙烯基乙基醚等,相對於式(1)表示的化合物或其鹽,其可使用10當量以上,並以30至100當量為佳,而以50至60當量更佳。 In addition, the isopropenyl alkyl ether used in this step may, for example, be isopropenylmethyl ether or isopropenylethyl ether, and may be used in combination with the compound represented by the formula (1) or a salt thereof. It is more than the equivalent and is preferably from 30 to 100 equivalents, more preferably from 50 to 60 equivalents.

此步驟中使用的溶劑,只要是不阻礙反應,可為某程度溶解起始物質的溶劑,無特別的限定,可列舉:例如苯、甲苯、二甲苯等芳香族烴類;二氯甲烷、氯仿、四氯化碳、二氯乙烷、氯苯、二氯苯等鹵化烴類;二乙基醚、二異丙基醚、四氫呋喃、環戊基甲基醚、甲基-第三丁基醚、二烷、二甲氧基乙烷、二乙二醇二甲基醚等醚類;醋酸乙酯、醋酸異丙酯等羧酸低級烷酯類;甲醯胺、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-四氫吡咯酮、六甲基磷三醯胺等醯胺類;二甲基亞碸、環丁碸等亞碸類;甲醇、乙醇、丙醇、異丙醇、丁醇、異丁醇、第三丁醇等低級醇類;水;或此等溶劑之混合溶劑,並以低級醇類與芳香族烴類為佳,而以甲醇與甲苯更佳。 The solvent to be used in this step is not particularly limited as long as it does not inhibit the reaction, and is a solvent which dissolves the starting material to some extent, and examples thereof include aromatic hydrocarbons such as benzene, toluene, and xylene; dichloromethane and chloroform. , halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether ,two Ethers such as alkane, dimethoxyethane, diethylene glycol dimethyl ether; lower alkyl carboxylic acids such as ethyl acetate and isopropyl acetate; formamide, N,N-dimethylformamidine Amidoxime such as amine, N,N-dimethylacetamide, N-methyl-2-tetrahydropyrrolidone, hexamethylphosphoric acid triamide, etc.; anthraquinones such as dimethyl hydrazine and cyclobutyl hydrazine; a lower alcohol such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol or tert-butanol; water; or a mixed solvent of such solvents, preferably lower alcohols and aromatic hydrocarbons; And methanol and toluene are better.

反應溫度雖然可依原料化合物、反應試藥而異,但 可在0℃至150℃中進行,並以25℃至130℃為佳,而以40℃至110℃為更佳。 Although the reaction temperature may vary depending on the starting compound and the reaction reagent, It can be carried out at 0 ° C to 150 ° C, preferably at 25 ° C to 130 ° C, and more preferably at 40 ° C to 110 ° C.

反應時間雖然可依反應溫度、原料化合物、反應試藥或使用的溶劑種類而異,但一般是12小時至96小時,並以24小時至84小時為佳。 Although the reaction time may vary depending on the reaction temperature, the starting compound, the reaction reagent or the type of solvent to be used, it is usually from 12 hours to 96 hours, and preferably from 24 hours to 84 hours.

反應完畢後,使反應液放冷,一邊在冰冷下攪拌,一邊添加水、氨水、甲醇等溶劑,將析出的固體過濾或進行濃縮、萃取操作,在濃縮後獲得的殘渣中添加甲苯、正己烷、正庚烷等可再結晶的溶劑後,過濾析出的固體,乾燥後即可得目的化合物。又,將析出的固體過濾之後,宜以甲苯、正己烷、正庚烷、水等洗淨。 After the reaction is completed, the reaction solution is allowed to cool, and while stirring under ice cooling, a solvent such as water, ammonia water or methanol is added, and the precipitated solid is filtered or concentrated, and extracted, and toluene and n-hexane are added to the residue obtained after concentration. After the recrystallizable solvent such as n-heptane, the precipitated solid is filtered and dried to obtain the desired compound. Further, after the precipitated solid is filtered, it is preferably washed with toluene, n-hexane, n-heptane, water or the like.

必要時,所得的目的化合物可由一般進行的方法精製,例如再結晶、再沉澱等。 When necessary, the obtained objective compound can be purified by a general method such as recrystallization, reprecipitation, or the like.

製造方法2 Manufacturing method 2

式(3)表示的化合物或其鹽,可依照以下的合成路徑2製造。 The compound represented by the formula (3) or a salt thereof can be produced according to the following synthesis route 2.

即,使用依照上述製造方法1之<步驟2>的製造方法,使式(1)表示的化合物或其鹽與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而得式(2)表示的化合物或其鹽。式(2)表示的化合物或其鹽可不進行管柱精製而得。而且,可使所得的式(2)表示之化合物或其鹽,在選自酸、鹼所形成之群組中的至少一種之存在下,與式(a)R0X 表示的化合物或其鹽反應,而製造式(3)表示的化合物或其鹽。式(3)表示的化合物或其鹽可不進行管柱精製而得。式(a)、(3)中,R0是表示對-甲氧基苯甲基或苯甲基氧基甲基。 In other words, the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether according to the production method of the <Step 2> of the above Production Method 1. 2) A compound or a salt thereof. The compound represented by the formula (2) or a salt thereof can be obtained without column column purification. Further, the compound represented by the formula (2) or a salt thereof, in the presence of at least one selected from the group consisting of an acid and a base, and a compound represented by the formula (a) R 0 X or a salt thereof The reaction is carried out to produce a compound represented by the formula (3) or a salt thereof. The compound represented by the formula (3) or a salt thereof can be obtained without column column purification. In the formulae (a) and (3), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.

式(a)中,X是表示脫離基,只要是可藉由反應而脫離的取代基均可,可列舉:例如氟原子、氯原子、溴原子、碘原子等鹵素原子、甲烷磺醯基氧基、氯甲基甲亞碸基氧基、三氟甲烷磺醯基氧基等低級烷基磺醯基氧基、苯磺醯基氧基、對-甲苯磺醯基氧基等芳基磺醯基氧基、氰基、硝基、三氯乙醯亞胺酯、羰基二氧基苯基等,並以鹵素原子為佳,而以氯原子更佳。 In the formula (a), X is a leaving group, and any substituent which can be removed by the reaction may be, for example, a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, or a methanesulfonyloxy group. An arylsulfonyl group such as a lower alkylsulfonyloxy group, a phenylsulfonyloxy group or a p-toluenesulfonyloxy group such as a chloromethylmethyleneoxy group or a trifluoromethanesulfonyloxy group; A oxy group, a cyano group, a nitro group, a trichloroethylene imidate, a carbonyl dioxyphenyl group, etc., preferably a halogen atom, and more preferably a chlorine atom.

相對於式(2)表示的化合物或其鹽,式(a)表示的化合物或其鹽可使用1當量以上,並以1至2當量為佳,而以1.2至1.5當量更佳。 With respect to the compound represented by the formula (2) or a salt thereof, the compound represented by the formula (a) or a salt thereof can be used in an amount of 1 equivalent or more, preferably 1 to 2 equivalents, more preferably 1.2 to 1.5 equivalents.

此步驟中使用的酸,可列舉:例如鹽酸、硫酸、硝酸、磷酸、溴化氫、氟酸等無機酸類;三氟醋酸、甲烷磺酸、三氟甲烷磺酸、苯磺酸、對-甲苯磺酸、胺基磺酸等有機酸類;三溴化硼、三氯化硼、三氟化硼、氯化鋁等路易斯酸等。 The acid used in this step may, for example, be an inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, hydrogen bromide or hydrofluoric acid; trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid or p-toluene; An organic acid such as a sulfonic acid or an aminosulfonic acid; a Lewis acid such as boron tribromide, boron trichloride, boron trifluoride or aluminum chloride; and the like.

相對於式(2)表示的化合物或其鹽,此步驟中可使用1當量以上的酸,並以1至5當量為佳,而以2至3當量更佳。 With respect to the compound represented by the formula (2) or a salt thereof, one equivalent or more of an acid may be used in this step, preferably from 1 to 5 equivalents, more preferably from 2 to 3 equivalents.

此步驟中使用的鹼,可列舉:例如碳酸鈉、碳酸鉀、碳酸銫、碳酸鋰等鹼金屬碳酸鹽類;碳酸氫鈉、碳酸氫鉀、碳酸氫鋰等鹼金屬碳酸氫鹽類;氫氧化鈉、氫氧化鉀、氫氧化鋇、氫氧化鋰等鹼金屬氫氧化物類;氫化鋰、氫化鈉、氫化鉀等鹼金屬氫化物類;氟化鈉、氟化鉀等鹼金屬氟化物類的無機鹼類;甲醇鈉、乙醇鈉、甲醇鉀、乙醇鉀、第三丁醇鉀、甲醇鋰等鹼金屬醇 鹽類;N-甲基嗎啉、三乙基胺、三丙基胺、三丁基胺、二異丙基乙基胺、二環己基胺、N-甲基哌啶、吡啶、4-吡咯基吡啶、甲基吡啶、4-(N,N-二甲基胺基)吡啶、2,6-二(第三丁基)-4-甲基吡啶、喹啉、N,N-二甲基苯胺、N,N-二乙基苯胺、1,5-二氮雜環[4.3.0]壬-5-烯(DBN)、1,4-二氮雜環[2.2.2]辛烷(DABCO)、1,8-二氮雜環[5.4.0]十一-7-烯(DBU)、N,N,N’,N’,N”,N”-六甲基磷酸三醯胺(HMPA)等有機鹼類,並以鹼金屬碳酸鹽類為佳,而以碳酸鉀更佳。 The base to be used in this step may, for example, be an alkali metal carbonate such as sodium carbonate, potassium carbonate, cesium carbonate or lithium carbonate; or an alkali metal hydrogencarbonate such as sodium hydrogencarbonate, potassium hydrogencarbonate or lithium hydrogencarbonate; Alkali metal hydroxides such as sodium, potassium hydroxide, barium hydroxide, lithium hydroxide; alkali metal hydrides such as lithium hydride, sodium hydride, and potassium hydride; alkali metal fluorides such as sodium fluoride and potassium fluoride Inorganic bases; alkali metal alcohols such as sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, potassium butoxide or lithium methoxide Salts; N-methylmorpholine, triethylamine, tripropylamine, tributylamine, diisopropylethylamine, dicyclohexylamine, N-methylpiperidine, pyridine, 4-pyrrole Pyridine, picoline, 4-(N,N-dimethylamino)pyridine, 2,6-di(t-butyl)-4-methylpyridine, quinoline, N,N-dimethyl Aniline, N,N-diethylaniline, 1,5-diazacyclo[4.3.0]non-5-ene (DBN), 1,4-diazacyclo[2.2.2]octane (DABCO) , 1,8-diazaheterocycle [5.4.0]undec-7-ene (DBU), N,N,N',N',N",N"-trimethylammonium phosphate (HMPA) And other organic bases, and alkali metal carbonates are preferred, and potassium carbonate is more preferred.

相對於式(2)表示的化合物或其鹽,此步驟中可使用1當量以上的鹼,並以1至5當量為佳,而以2至3當量更佳。 With respect to the compound represented by the formula (2) or a salt thereof, 1 equivalent or more of a base may be used in this step, preferably 1 to 5 equivalents, and more preferably 2 to 3 equivalents.

此步驟中使用的溶劑,只要是不阻礙反應,可為某程度溶解起始物質的溶劑,無特別的限定,可列舉:例如苯、甲苯、二甲苯等芳香族烴類;二氯甲烷、氯仿、四氯化碳、二氯乙烷、氯苯、二氯苯等鹵化烴類;二乙基醚、二異丙基醚、四氫呋喃、環戊基甲基醚、甲基-第三丁基醚、二烷、二甲氧基乙烷、二乙二醇二甲基醚等醚類;醋酸乙酯、醋酸異丙酯等羧酸低級烷酯類;甲醯胺、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-四氫吡咯酮、六甲基磷三醯胺等醯胺類;二甲基亞碸、環丁碸等亞碸類;甲醇、乙醇、丙醇、異丙醇、丁醇、異丁醇、第三丁醇等低級醇類;水;或此等溶劑之混合溶劑,並以醯胺類與水為佳,而以N,N-二甲基甲醯胺與水更佳。 The solvent to be used in this step is not particularly limited as long as it does not inhibit the reaction, and is a solvent which dissolves the starting material to some extent, and examples thereof include aromatic hydrocarbons such as benzene, toluene, and xylene; dichloromethane and chloroform. , halogenated hydrocarbons such as carbon tetrachloride, dichloroethane, chlorobenzene, dichlorobenzene; diethyl ether, diisopropyl ether, tetrahydrofuran, cyclopentyl methyl ether, methyl-tert-butyl ether ,two Ethers such as alkane, dimethoxyethane, diethylene glycol dimethyl ether; lower alkyl carboxylic acids such as ethyl acetate and isopropyl acetate; formamide, N,N-dimethylformamidine Amidoxime such as amine, N,N-dimethylacetamide, N-methyl-2-tetrahydropyrrolidone, hexamethylphosphoric acid triamide, etc.; anthraquinones such as dimethyl hydrazine and cyclobutyl hydrazine; a lower alcohol such as methanol, ethanol, propanol, isopropanol, butanol, isobutanol or tert-butanol; water; or a mixed solvent of such solvents, preferably with amidoxime and water, N,N-dimethylformamide is preferred with water.

反應溫度雖然可依原料化合物、反應試藥而異,但可在0℃至100℃中進行,並以0℃至50℃為佳。 Although the reaction temperature may vary depending on the starting compound and the reaction reagent, it may be carried out at 0 ° C to 100 ° C, preferably 0 ° C to 50 ° C.

反應時間雖然可依反應溫度、原料化合物、反應試藥或使用的溶劑種類而異,但一般是1小時至48小時,並以2小時至5小 時為佳。 Although the reaction time may vary depending on the reaction temperature, the starting compound, the reaction reagent or the type of solvent to be used, it is usually from 1 hour to 48 hours, and is from 2 hours to 5 hours. Time is better.

反應完畢後,使反應液放冷,一邊在冰冷下攪拌,一邊添加水、氨水、甲醇等溶劑,將析出之固體過濾或進行萃取操作,在濃縮後獲得的殘渣中添加甲苯、醋酸乙酯等可再結晶之溶劑,過濾析出的固體,乾燥後即可得目的化合物。又,將析出的固體過濾之後,宜以甲苯、醋酸乙酯、水等洗淨。 After the reaction is completed, the reaction solution is allowed to cool, and while stirring under ice cooling, a solvent such as water, ammonia water or methanol is added, and the precipitated solid is filtered or subjected to an extraction operation, and toluene, ethyl acetate or the like is added to the residue obtained after concentration. The solvent which can be recrystallized, the precipitated solid is filtered, and after drying, the objective compound can be obtained. Further, after the precipitated solid is filtered, it is preferably washed with toluene, ethyl acetate, water or the like.

必要時,所得的目的化合物可由一般進行的方法精製,例如再結晶、再沉澱等。 When necessary, the obtained objective compound can be purified by a general method such as recrystallization, reprecipitation, or the like.

製造方法3 Manufacturing method 3

式(2)表示的化合物或其鹽,也可依照以下的合成路徑3製造。 The compound represented by the formula (2) or a salt thereof can also be produced according to the following synthesis route 3.

即,使用比照上述製造方法1之<步驟2>的製造方法,使式(1)表示的化合物或其鹽與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而獲得式(4)表示的化合物或其鹽,並且可使用依照上述製造方法1之<步驟2>的製造方法而使獲得的式(4)表示的化合物或其鹽,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而製造式(2)表示的化合物或其鹽。 In other words, the compound represented by the formula (1) or a salt thereof is reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether according to the production method of the <Step 2> of the above Production Method 1 to obtain a formula ( And a salt of the compound represented by the formula (4) or a salt thereof, and a 2,2-dialkoxypropane, which can be obtained by the production method according to the <Step 2> of the above Production Method 1 The compound represented by the formula (2) or a salt thereof is produced by reacting with isopropenylalkyl ether.

製造方法4 Manufacturing method 4

式(3)表示的化合物或其鹽,也可依照以下的合成路徑4製造。 The compound represented by the formula (3) or a salt thereof can also be produced according to the following synthesis route 4.

即,使式(1)表示的化合物或其鹽在選自酸、鹼所形成之群組中的至少一種之存在下,與式(a)R0X表示的化合物或其鹽反應,可得式(8)表示的化合物或其鹽。接著,可使用依照上述製造方法1之<步驟2>的製造方法,使所得的式(8)表示之化合物或其鹽與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而製造式(3)表示的化合物或其鹽。又,也可使由式(8)表示之化合物或其鹽製造式(3)表示的化合物或其鹽的反應,經由反應中途生成的式(4b)表示之化合物或其鹽而進行。式(a)、(8)、(3)、(4b)中,R0是表示對-甲氧基苯甲基或苯甲基氧基甲基。 In other words, the compound represented by the formula (1) or a salt thereof is reacted with a compound represented by the formula (a) R 0 X or a salt thereof in the presence of at least one selected from the group consisting of an acid and a base. A compound represented by the formula (8) or a salt thereof. Next, the obtained compound represented by the formula (8) or a salt thereof can be reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether using the production method according to <Step 2> of the above Production Method 1. A compound represented by the formula (3) or a salt thereof is produced. In addition, the reaction of the compound represented by the formula (8) or a salt thereof to produce the compound represented by the formula (3) or a salt thereof can be carried out by a compound represented by the formula (4b) produced in the middle of the reaction or a salt thereof. In the formulae (a), (8), (3), and (4b), R 0 represents a p-methoxybenzyl group or a benzyloxymethyl group.

製造方法5 Manufacturing method 5

化合物(2a),也可依照以下的合成路徑5製造。 The compound (2a) can also be produced according to the following synthesis route 5.

即,藉由使與鹵化物(9a)對應的硼酸(b)在DMF等溶劑中,於碳酸鈉等鹼與二氯化雙(三苯基膦)鈀(Ⅱ)等觸媒的存在下反應,可得化合物(10a)。將獲得的化合物(10a)於氫氣周圍環境下接觸還原而得化合物(11a),接著使用依照上述製造方法1之<步驟2>的製造方法,使化合物(11a)與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而得化合物(12a)。然後,可使獲得的化合物(12a)閉環而製造化合物(2a)。 In other words, the boric acid (b) corresponding to the halide (9a) is reacted in a solvent such as DMF with a base such as sodium carbonate or a catalyst such as bis(triphenylphosphine)palladium(II) dichloride. The compound (10a) is available. The obtained compound (10a) is contact-reduced under a hydrogen atmosphere to obtain a compound (11a), followed by a production method according to <Step 2> of the above Production Method 1, to give a compound (11a) and 2,2-dialkoxy The compound (12a) is obtained by reacting a propane or an isopropenyl alkyl ether. Then, the obtained compound (12a) can be ring-closed to produce a compound (2a).

製造方法6 Manufacturing method 6

化合物(2a)也可依照以下的合成路徑6製造。 Compound (2a) can also be produced according to the following synthetic route 6.

即,可使用依照上述製造方法1之<步驟2>的製造方法,使化合物(13a)與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而得化合物(14a)。使獲得的化合物(14a)之羧基進行甲基酯化,而得化合物(15a),使與獲得的化合物(15a)對應之硼酸(b)在DMF等溶劑中,於碳酸鈉等鹼與二氯化雙(三苯基膦)鈀(Ⅱ)等觸媒的存在下反應,可得化合物(12a)。可使獲得的化合物(12a)閉環而製造化 合物(2a)。同時,也可使用依照上述製造方法1之<步驟2>的製造方法,使化合物(16a)與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而得化合物(15a)。 That is, the compound (13a) can be obtained by reacting the compound (13a) with 2,2-dialkoxypropane or isopropenyl alkyl ether according to the production method of <Step 2> of the above Production Method 1. The carboxyl group of the obtained compound (14a) is subjected to methyl esterification to obtain a compound (15a), the boric acid (b) corresponding to the obtained compound (15a) is used in a solvent such as DMF, and a base such as sodium carbonate and dichloro The compound (12a) can be obtained by reacting in the presence of a catalyst such as bis(triphenylphosphine)palladium (II). The obtained compound (12a) can be produced by ring closure Compound (2a). Meanwhile, the compound (15a) can also be obtained by reacting the compound (16a) with 2,2-dialkoxypropane or isopropenyl alkyl ether according to the production method of <Step 2> of the above Production Method 1.

製造方法7 Manufacturing method 7

化合物(7)表示的化合物或其鹽,可依照以下的合成路徑7製造。 The compound represented by the compound (7) or a salt thereof can be produced according to the following synthesis route 7.

即,可使用依照上述製造方法1之<步驟2>的製造方法,使式(6)表示的化合物或其鹽與2,2-二烷氧基丙烷或異丙烯基烷基醚反應而製造。 In other words, the compound represented by the formula (6) or a salt thereof can be produced by reacting the compound represented by the formula (6) with 2,2-dialkoxypropane or isopropenyl alkyl ether according to the production method of the <Step 2> of the above Production Method 1.

式(6)及式(7)中,R1可舉出鹵素原子、低級烷基、羥基、低級烷氧基、低級烷基羰基、羧基、胺基、硝基或氰基,以氫原子為佳。p可舉出0至4的整數,以1至2為佳。 In the formulae (6) and (7), R 1 may, for example, be a halogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amine group, a nitro group or a cyano group. good. p may be an integer of 0 to 4, preferably 1 to 2.

以下表示本發明的製造例。又,此等例示是可更充分理解本發明之例,並非限定本發明的範圍。 The production example of the present invention is shown below. Further, the examples are intended to provide a more complete understanding of the invention and are not intended to limit the scope of the invention.

[製造例] [Manufacturing example]

<8-胺基-3-羥基苯并[c]苯并吡喃-6-酮對-甲苯磺酸鹽(1a)之製造> <Production of <8-Amino-3-hydroxybenzo[c]benzopyran-6-one p-toluenesulfonate (1a)>

將8-乙醯醯胺-3-羥基-6H-苯并[c]苯并吡喃-6-酮(5a)(60.0g,223mmol,國際公開2012/108455小冊)與乙醇(900mL)、水(120mL)之混合液在室溫攪拌,加入對-甲苯磺酸一水合物(127g,669mmol),以內溫79至81℃攪拌17小時。並且追加對-甲苯磺酸一水合物(42.3g,223mmol),以內溫79至81℃攪拌5小時。將反應液以內溫0至5℃攪拌1小時,將結晶過濾分離,以乙醇(300mL)洗淨後,以50℃減壓乾燥而獲得標記化合物(77.1g,產率86.5%)。 8-Acetylamine-3-hydroxy-6H-benzo[c]benzopyran-6-one (5a) (60.0 g, 223 mmol, International Publication 2012/108455 booklet) and ethanol (900 mL), The mixture of water (120 mL) was stirred at room temperature, p-toluenesulfonic acid monohydrate (127 g, 669 mmol) was added, and the mixture was stirred at an internal temperature of 79 to 81 ° C for 17 hours. Further, p-toluenesulfonic acid monohydrate (42.3 g, 223 mmol) was added, and the mixture was stirred at an internal temperature of 79 to 81 ° C for 5 hours. The reaction liquid was stirred at an internal temperature of 0 to 5 ° C for 1 hour, and the crystals were separated by filtration, washed with ethanol (300 mL), and dried under reduced pressure at 50 ° C to give the title compound (77.1 g, yield 86.5%).

<8-羥基-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(2a)之製造1> Manufacture of <8-hydroxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-aza--5-one (2a) 1>

將2,2-二甲氧基丙烷(59.0mL,482mmol)、吡啶(0.70mL,8.71mmol)與水(3.20mL,178mmol)之混合液在室溫攪拌,加入8-胺基-3-羥基苯并[c]苯并吡喃-6-酮對-甲苯磺酸鹽(1a)(3.51g,8.79mmol),耐壓條件下以外溫105℃攪拌72小時。將反應液放冷冷卻、濃縮後,在殘渣中加入四氫呋喃(17.5mL)、醋酸乙酯(24.5mL)、水(21.0mL) 而萃取。以醋酸乙酯(24.5mL)萃取水層後,將有機層匯集,以水(21.0mL)洗淨2次,以4%碳酸氫鈉水溶液(21.0mL)洗淨,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製數次,獲得標記化合物(1.30g,產率48%)。 A mixture of 2,2-dimethoxypropane (59.0 mL, 482 mmol), pyridine (0.70 mL, 8.71 mmol) and water (3.20 mL, 178 mmol) was stirred at rt. Benzo[c]benzopyran-6-one p-toluenesulfonate (1a) (3.51 g, 8.79 mmol) was stirred at an external temperature of 105 ° C for 72 hours under pressure. After cooling and concentrating the reaction mixture, tetrahydrofuran (17.5 mL), ethyl acetate (24.5 mL) and water (21.0 mL) were added to the residue. And extract. The aqueous layer was extracted with ethyl acetate (24.5 mL), and the organic layer was combined, washed twice with water (21.0 mL), and washed with 4% aqueous sodium hydrogen carbonate (21.0 mL). The concentrated residue was purified by a silica gel column chromatography (ethyl acetate-hexane) to give the title compound (1.30 g, yield 48%).

<8-(4-甲氧基苯甲基氧基)-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(3a)之製造1> <8-(4-Methoxybenzyloxy)-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacyclo-5-one (3a) Manufacturing 1>

將8-胺基-3-羥基苯并[c]苯并吡喃-6-酮(1b)(5.00g,22.0mmol)、2,2-二甲氧基丙烷(135.0mL,1102mmol)、吡啶(1.77mL,22.0mmol)與水(7.90mL,438mmol)之混合液在室溫攪拌,加入對-甲苯磺酸一水合物(4.19g,22.0mmol),耐壓條件下,以外溫105℃攪拌 66小時10分鐘。將反應液放冷冷卻、濃縮後,在殘渣中加入醋酸乙酯-四氫呋喃(3:2,100.0mL)、飽和碳酸氫鈉水溶液(50.0mL)而進行萃取。以醋酸乙酯-四氫呋喃(3:2,50.0mL)萃取水層2次後,將有機層匯集,以飽和碳酸氫鈉水溶液(50.0mL)洗淨3次,濃縮有機層。在濃縮殘渣中加入N,N-二甲基甲醯胺(60.0mL),進行數次濃縮之操作,將吡啶去除。加入N,N-二甲基甲醯胺以使濃縮殘渣成為60.0mL,加入碳酸鉀(7.61g,55.1mmol)、水(3.00mL),在室溫攪拌。在此混合液中加入4-甲氧基苯甲基氯(3.9mL,28.6mmol),以外溫40℃攪拌3小時25分鐘。將反應液以冰冷攪拌,加入水(300.0mL),攪拌1小時15分鐘,過濾後,以水(100.0mL)洗淨。將粗體的標記化合物與醋酸乙酯(300.0mL)之混合液以外溫85℃攪拌、過濾,濃縮濾液。在濃縮殘渣中加入甲苯(46.0mL)、醋酸乙酯(12.0mL),以外溫85℃攪拌1小時。將反應液以0℃攪拌18小時50分鐘,過濾後,以甲苯(15.0mL)洗淨,以50℃減壓乾燥,獲得標記化合物(4.10g,產率44%)。 8-Amino-3-hydroxybenzo[c]benzopyran-6-one (1b) (5.00 g, 22.0 mmol), 2,2-dimethoxypropane (135.0 mL, 1102 mmol), pyridine (1.77 mL, 22.0 mmol) and a mixture of water (7.90 mL, 438 mmol) were stirred at room temperature, p-toluenesulfonic acid monohydrate (4.19 g, 22.0 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C under pressure. 66 hours and 10 minutes. The reaction mixture was cooled, cooled and concentrated, and ethyl acetate-tetrahydrofuran (3:2, 100.0 mL) and saturated aqueous sodium hydrogen carbonate (50.0 mL) were added to the residue to extract. The aqueous layer was extracted twice with ethyl acetate-tetrahydrofuran (3:2, 50.0 mL). The organic layer was collected and washed three times with saturated aqueous sodium hydrogen carbonate (50.0 mL). N,N-dimethylformamide (60.0 mL) was added to the concentrated residue, and the mixture was concentrated several times to remove pyridine. N,N-dimethylformamide was added to make 60.0 mL of a concentrated residue, and potassium carbonate (7.61 g, 55.1 mmol) and water (3.00 mL) were added, and stirred at room temperature. 4-Methoxybenzyl chloride (3.9 mL, 28.6 mmol) was added to the mixture, and the mixture was stirred at 40 ° C for 3 hours and 25 minutes. The reaction solution was stirred with ice cold, water (300.0 mL) was added, and the mixture was stirred for 1 hour and 15 minutes, filtered, and washed with water (100.0 mL). The mixture of the crude labeled compound and ethyl acetate (300.0 mL) was stirred at 85 ° C, filtered, and the filtrate was concentrated. Toluene (46.0 mL) and ethyl acetate (12.0 mL) were added to the residue, and the mixture was stirred at an external temperature of 85 ° C for 1 hour. The reaction mixture was stirred at 0 ° C for 18 hours and 50 minutes. After filtered, washed with toluene (15.0 mL), and dried under reduced pressure at 50 ° C to give the title compound (4.10 g, yield 44%).

<8-(4-甲氧基苯甲基氧基)-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(3a)之製造2> <8-(4-Methoxybenzyloxy)-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacyclo-5-one (3a) Manufacturing 2>

將2,2-二甲氧基丙烷(717.28g,6887mmol)、吡啶(9.90g,125.2mmol)與水(45.12g,2504mmol)的混合液以室溫攪拌,加入8-胺基-3-羥基苯并[c]苯并吡喃-6-酮對-甲苯磺酸鹽(1a)(50.00g,125.2mmol),耐壓條件下,以內溫90.5至98.5℃攪拌72小時。將反應液放冷冷卻、減壓濃縮後,在殘渣中加入醋酸乙酯(313g)、四氫呋喃(222g)、水(300g),使其分層。將有機層以水(300g)二次、4%碳酸氫鈉水溶液(300g)洗淨後,加入四氫呋喃(222g),以4%碳酸氫鈉水溶液(302g)洗淨。在有機層中加入N,N-二甲基甲醯胺(327.30g),進行減壓濃縮。濃縮後,加入N,N-二甲基甲醯胺以使濃縮殘渣成為327.05g,加入碳酸鉀(42.51g,307.59mmol)、水(14.70g),以室溫攪拌。在此混合液中加入4-甲氧基苯甲基氯(25.07g,160.08mmol),以內溫40至41℃攪拌4小時。將反應液冷卻至室溫,加入醋酸乙酯(232g)、四氫呋喃(686g)、28%氨水(705g)攪拌,使其分層。在水層中加入醋酸乙酯(310g),使其分層。匯集全部的有機層,以5%食鹽水(786g)洗淨1次,以5%食鹽水(393g)洗淨2次,以水(400g)洗淨1次,將有機層減壓濃縮。加入甲苯(213g),進行 減壓濃縮的操作3次,在濃縮殘渣中加入甲苯(221.34g)、醋酸乙酯(35.4g),以內溫84至90℃攪拌31分鐘後,以內溫1至10℃攪拌18小時,將析出的固體過濾。將取得的濕晶與甲苯(128g)的混合液以內溫85℃攪拌1小時13分鐘後,使其冷卻。以內溫1至10℃攪拌2小時59分鐘後,過濾,以甲苯(20g)洗淨3次,以50℃減壓乾燥2小時15分鐘,獲得標記化合物(19.41g,產率36.3%)。 A mixture of 2,2-dimethoxypropane (717.28 g, 6887 mmol), pyridine (9.90 g, 125.2 mmol) and water (45.12 g, 2504 mmol) was stirred at room temperature, and 8-amino-3-hydroxyl was added. Benzo[c]benzopyran-6-one p-toluenesulfonate (1a) (50.00 g, 125.2 mmol) was stirred at an internal temperature of 90.5 to 98.5 ° C for 72 hours under pressure. The reaction solution was cooled and cooled, and concentrated under reduced pressure. ethyl acetate (313 g), THF ( 222 g), and water (300 g) were added to the residue. The organic layer was washed twice with water (300 g) and 4% aqueous sodium hydrogencarbonate (300 g), and then evaporated to THF (2,2 g) and washed with 4% aqueous sodium hydrogencarbonate (302 g). N,N-dimethylformamide (327.30 g) was added to the organic layer, and concentrated under reduced pressure. After concentration, N,N-dimethylformamide was added to make the concentrated residue 327.05 g, and potassium carbonate (42.51 g, 307.59 mmol) and water (14.70 g) were added and stirred at room temperature. 4-Methoxybenzyl chloride (25.07 g, 160.08 mmol) was added to the mixture, and the mixture was stirred at an internal temperature of 40 to 41 ° C for 4 hours. The reaction liquid was cooled to room temperature, and ethyl acetate (232 g), tetrahydrofuran (686 g), and 28% aqueous ammonia (705 g) were added and stirred, and the layers were separated. Ethyl acetate (310 g) was added to the aqueous layer to separate the layers. The whole organic layer was collected, washed once with 5% aqueous sodium chloride (786 g), washed twice with 5% brine (393 g), and washed once with water (400 g). Add toluene (213g) for The mixture was concentrated under reduced pressure three times. Toluene (221.34 g) and ethyl acetate (35.4 g) were added to the residue. The mixture was stirred at an internal temperature of 84 to 90 ° C for 31 minutes, and then stirred at an internal temperature of 1 to 10 ° C for 18 hours to precipitate. Solid filtration. The obtained mixture of wet crystals and toluene (128 g) was stirred at an internal temperature of 85 ° C for 1 hour and 13 minutes, and then cooled. After stirring at an internal temperature of 1 to 10 ° C for 2 hours and 59 minutes, the mixture was filtered, washed with toluene (20 g) three times, and dried under reduced pressure at 50 ° C for 2 hours and 15 minutes to obtain a labeled compound (19.41 g, yield 36.3%).

<8-胺基-3-羥基苯并[c]苯并吡喃-6-酮(1b)之製造> <Production of <8-Amino-3-hydroxybenzo[c]benzopyran-6-one (1b)>

將8-胺基-3-羥基苯并[c]苯并吡喃-6-酮對-甲苯磺酸鹽(1a)(8.02g,20.1mmol)與甲醇(40.0mL)的混合液以冰冷攪拌。使內溫成為3℃時加入碳酸氫鈉(2.02g,24.0mmol),將外溫返回至室溫,攪拌2小時。將反應液中的固體過濾,以水(30.0mL)洗淨後,以50℃乾燥,獲得標記化合物(4.58g,產率100%)。 A mixture of 8-amino-3-hydroxybenzo[c]benzopyran-6-one p-toluenesulfonate (1a) (8.02 g, 20.1 mmol) and methanol (40.0 mL) was stirred with ice cold. . When the internal temperature was 3 ° C, sodium hydrogencarbonate (2.02 g, 24.0 mmol) was added, and the external temperature was returned to room temperature, followed by stirring for 2 hours. The solid in the reaction mixture was filtered, washed with water (30.0 mL), and dried at 50 ° C to give the title compound (4.58 g, yield 100%).

<8-(1,1-二甲基-3-側氧基丁基胺基)-3-羥基苯并[c]苯并吡喃-6-酮(4a)之製造> Production of <8-(1,1-dimethyl-3-oxobutylbutylamino)-3-hydroxybenzo[c]benzopyran-6-one (4a) >

將8-胺基-3-羥基苯并[c]苯并吡喃-6-酮(1b)(5.00g,22.0mmol)、2,2-二甲氧基丙烷(135mL,1100mmol)、吡啶(1.76mL,21.9mmol)與水(7.90mL,440mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(4.15g,21.8mmol),在其懸浮液中加入1-甲基-2-四氫吡咯酮(125mL)攪拌溶解,攪拌66小時40分鐘。濃縮反應液,加入醋酸乙酯(1000mL)、飽和雙層水(500mL)進行萃取。以醋酸乙酯(500mL)萃取水層2次後,將有機層匯集,以水(500mL)洗淨3次。濃縮有機層,在殘渣中加入氯仿,過濾後,濃縮濾液。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(2.66g,產率37%)。 8-Amino-3-hydroxybenzo[c]benzopyran-6-one (1b) (5.00 g, 22.0 mmol), 2,2-dimethoxypropane (135 mL, 1100 mmol), pyridine ( A mixture of 1.76 mL, 21.9 mmol) and water (7.90 mL, 440 mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (4.15 g, 21.8 mmol) was added, and 1-methyl- 2-Tetrahydropyrrolidone (125 mL) was stirred and dissolved, and stirred for 66 hours and 40 minutes. The reaction solution was concentrated, and ethyl acetate (1000 mL) and saturated double water (500 mL) were added to extract. After extracting the aqueous layer twice with ethyl acetate (500 mL), the organic layer was collected and washed three times with water (500 mL). The organic layer was concentrated, chloroform was added to the residue, and the filtrate was concentrated. The residue was purified with EtOAc (EtOAc) elute

<8-羥基-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(2a)之製造2> Manufacture of <8-hydroxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-aza--5-one (2a) 2>

將8-(1,1-二甲基-3-側氧基丁基胺基)-3-羥基苯并[c]苯并吡喃-6-酮(4a)(0.76g,2.34mmol)、2,2-二甲氧基丙烷(16.0mL,131mmol)、吡啶(0.19mL,2.36mmol)與水(0.84mL,46.6mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(0.45g,2.36mmol),耐壓條件下,以外溫105℃攪拌61.5小時。將反應液放冷冷卻,加入醋酸乙酯(5.50mL)、四氫呋喃(4.00mL)、水(4.50mL)進行萃取。以水(4.50mL)將有機層洗淨後,匯集水層,以醋酸乙酯(5.50mL)萃取,將有機層匯集,以4%碳酸氫鈉水溶液(4.50mL)洗淨,以無水硫酸鎂乾燥後,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(0.37g,產率51.2%)。 8-(1,1-Dimethyl-3-oxobutylamino)-3-hydroxybenzo[c]benzopyran-6-one (4a) (0.76 g, 2.34 mmol), A mixture of 2,2-dimethoxypropane (16.0 mL, 131 mmol), pyridine (0.19 mL, 2.36 mmol) and water (0.84 mL, 46.6 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate was added. (0.45 g, 2.36 mmol), and stirred at an external temperature of 105 ° C for 61.5 hours under pressure. The reaction solution was cooled and cooled, and ethyl acetate (5.50 mL), tetrahydrofuran (4.00 mL), and water (4.50 mL) were added to extract. The organic layer was washed with water (4.50 mL), and then aqueous layer was evaporated, ethyl acetate (5. 5 mL), and the organic layer was collected and washed with 4% aqueous sodium hydrogencarbonate (4.50 mL). After drying, the organic layer was concentrated. The residue was purified by silica gel chromatography (ethyl acetate-hexane) to give the title compound (0.37 g, yield: 51.2%).

<8-胺基-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮(8a)之製造> <Production of <8-Amino-3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one (8a)>

將8-胺基-3-羥基苯并[c]苯并吡喃-6-酮(1b)(2.00g,8.80mmol)與無水二甲基甲醯胺(40.0mL)的混合液以冷卻外溫冰冷攪拌。使內溫成為4℃時加入60%氫化鈉(0.42g,10.5mmol),再加入4-甲氧基苯甲基氯(1.40mL,10.3mmol),使外溫返回至室溫,攪拌14小時55分鐘。將反應液放冷後以冰冷下攪拌,加水(40.0mL)攪拌43分鐘之後,將析出的固體過濾。再以水(20.0mL)將濾出物洗淨後,以65℃乾燥後獲得標記化合物(2.87g,產率94%)。 A mixture of 8-amino-3-hydroxybenzo[c]benzopyran-6-one (1b) (2.00 g, 8.80 mmol) and anhydrous dimethylformamide (40.0 mL) was cooled Stir in cold ice. When the internal temperature was 4 ° C, 60% sodium hydride (0.42 g, 10.5 mmol) was added, and then 4-methoxybenzyl chloride (1.40 mL, 10.3 mmol) was added, and the external temperature was returned to room temperature, and stirred for 14 hours. 55 minutes. The reaction solution was allowed to cool, then stirred with ice-cooled, and water (40.0 mL) was stirred for 43 minutes, and then the precipitated solid was filtered. The filtrate was washed with water (20.0 mL), and dried at 65 ° C to give the title compound (2.87 g, yield 94%).

<8-胺基-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮(8b)之製造> <Production of <8-Amino-3-benzyloxymethoxybenzo[c]benzopyran-6-one (8b)>

將8-胺基-3-羥基苯并[c]苯并吡喃-6-酮(1b)(2.00g,8.80mmol)與無水二甲基甲醯胺(40.0mL)的混合液以冷卻外溫冰冷攪拌。使內溫成為0.4℃時,加入60%氫化鈉(0.42g,10.5mmol),進一步再加入苯甲基氯甲基醚(1.45ml,10.5mmol),使外溫返回至室溫,攪拌2小時8分鐘。將反應液放冷後以冰冷下攪拌,加水(80.0mL)攪拌1小時之後,將析出的固體過濾。再以水(30.0mL)將濾出物洗淨後,以50℃乾燥。將取得物(3.24g)與甲醇(64.0mL)的混合液加熱迴流,攪拌1小時。將混合液放冷後以冰冷下攪拌1小時5分鐘,將其過濾。再以甲醇(5.00mL)將濾出物洗淨後,以50℃乾燥,獲得標記化合物(2.59g,產率85%)。 A mixture of 8-amino-3-hydroxybenzo[c]benzopyran-6-one (1b) (2.00 g, 8.80 mmol) and anhydrous dimethylformamide (40.0 mL) was cooled Stir in cold ice. When the internal temperature was 0.4 ° C, 60% sodium hydride (0.42 g, 10.5 mmol) was added, and further benzyl chloromethyl ether (1.45 ml, 10.5 mmol) was added, and the external temperature was returned to room temperature, and stirred for 2 hours. 8 minutes. The reaction solution was allowed to stand to cool, then stirred under ice-cooling, and water (80.0 mL) was stirred for 1 hour, and then the precipitated solid was filtered. The filtrate was washed with water (30.0 mL) and dried at 50 °C. A mixed liquid of the obtained product (3.24 g) and methanol (64.0 mL) was heated under reflux and stirred for 1 hour. The mixture was allowed to cool, and then stirred under ice cooling for 1 hour and 5 minutes, and then filtered. The filtrate was washed with methanol (5.00 mL), and then dried at 50 &lt;0&gt;C to give the title compound (2.59 g, yield: 85%).

<8-(4-甲氧基苯甲基氧基)-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(3a)之製造3> <8-(4-Methoxybenzyloxy)-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacyclo-5-one (3a) Manufacturing 3>

將8-胺基-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮(8a)(0.83g,2.39mmol)、2,2-二甲氧基丙烷(16.0mL,131mmol)、吡啶(0.19mL,2.36mmol)與水(0.86mL,47.7mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(0.45g,2.37mmol),耐壓條件下,以外溫75℃攪拌141小時35分鐘。將反應液放冷冷卻、濃縮後,在殘渣中加入醋酸乙酯(10.0mL)、四氫呋喃(14.0mL)、水(12.0mL)進行萃取。以醋酸乙酯(10.0mL)萃取水層後,將有機層匯集,以4%碳酸氫鈉水溶液(12.0mL)洗淨,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(氯仿)精製,獲得粗體的標記化合物(0.32g)。在粗體中加入甲苯(3.20mL)、正庚烷(3.20mL),以外溫80℃攪拌40分鐘,以外溫4℃冷卻,攪拌18小時20分鐘,過濾,以甲苯及正庚烷的混合溶劑(1:2,6.00mL)洗淨,獲得標記化合物(0.24g,產率20%)。 8-Amino-3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one (8a) (0.83 g, 2.39 mmol), 2,2-dimethyl A mixture of oxypropane (16.0 mL, 131 mmol), pyridine (0.19 mL, 2.36 mmol) and water (0.86 mL, 47.7 mmol) was stirred at room temperature and p-toluenesulfonic acid monohydrate (0.45 g, 2.37 mmol) Under the pressure condition, the mixture was stirred at an external temperature of 75 ° C for 141 hours and 35 minutes. The reaction mixture was cooled, cooled and concentrated, and ethyl acetate (10.0 mL), tetrahydrofuran (14.0 mL), and water (12.0 mL) were added to the residue. After extracting the aqueous layer with ethyl acetate (10.0 mL), the organic layer was collected, washed with 4% aqueous sodium hydrogen carbonate (12.0 mL), and the organic layer was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) to afford crude compound (0.32 g). Toluene (3.20 mL) and n-heptane (3.20 mL) were added to the crude, and the mixture was stirred at an external temperature of 80 ° C for 40 minutes, cooled at an external temperature of 4 ° C, stirred for 18 hours and 20 minutes, and filtered to obtain a mixed solvent of toluene and n-heptane. (1:2, 6.00 mL) was washed to give the title compound (0.24 g, yield 20%).

<8-(1,1-二甲基-3-側氧基丁基胺基)-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮(4b-1)之製造> <8-(1,1-Dimethyl-3-oxobutylbutylamino)-3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one (4b-1) Manufacturing>

將8-胺基-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮(8a)(2.51g,7.23mmol)、2,2-二甲氧基丙烷(49.0mL,400mmol)、吡啶(0.58mL,7.22mmol)與水(7.90mL,144mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(1.37g,7.20mmol),在其懸浮液中加入1-甲基-2-四氫吡咯酮(35mL)溶解,攪拌71小時4分鐘。將反應液濃縮,加入醋酸乙酯(50.0mL)、水(100mL)進行萃取。以醋酸乙酯(50.0mL)萃取水層後,將有機層匯集,加入醋酸乙酯(100mL)、水(100mL)萃取後,在有機層中加入醋酸乙酯(100mL)、四氫呋喃(20mL)、水(100mL)萃取,在有機層中加入醋酸乙酯(100mL)、水(100mL)進行萃取。濃縮有機層,在殘渣中加入四氫呋喃,將固體過濾後,濃縮濾液。在濃縮殘渣中加入醋酸乙酯,過濾固體後,濃縮濾液。在過濾的固體中加入氯仿溶解、濃縮,將析出的結晶 過濾後,濃縮濾液。在濃縮殘渣中加入氯仿,溶解濃縮,將析出的結晶過濾,濃縮濾液。將各別的濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,匯合各區分而獲得標記化合物(1.17g,產率37%)。 8-Amino-3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one (8a) (2.51 g, 7.23 mmol), 2,2-dimethyl A mixture of oxypropane (49.0 mL, 400 mmol), pyridine (0.58 mL, 7.22 mmol) and water (7.90 mL, 144 mmol) was stirred at room temperature and p-toluenesulfonic acid monohydrate (1.37 g, 7.20 mmol) was added. The mixture was dissolved in 1-methyl-2-tetrahydropyrrolidone (35 mL) and stirred for 71 hours and 4 minutes. The reaction solution was concentrated, and ethyl acetate (50.0 mL) and water (100 mL) After extracting the aqueous layer with ethyl acetate (50.0 mL), the organic layer was combined, and ethyl acetate (100 mL) and water (100 mL) were added to the mixture, and ethyl acetate (100 mL) and tetrahydrofuran (20 mL) were added to the organic layer. Water (100 mL) was extracted, and ethyl acetate (100 mL) and water (100 mL) were added to the organic layer to extract. The organic layer was concentrated, tetrahydrofuran was added to the residue, the solid was filtered, and the filtrate was concentrated. Ethyl acetate was added to the concentrated residue, and the solid was filtered, and the filtrate was concentrated. Adding chloroform to the filtered solid, dissolving and concentrating, and crystallizing the precipitate After filtration, the filtrate was concentrated. Chloroform was added to the concentrated residue, dissolved and concentrated, and the precipitated crystals were filtered, and the filtrate was concentrated. Each of the concentrated residue was purified by a silica gel column chromatography (ethyl acetate-hexane), and the fractions were combined to obtain a labeled compound (1.17 g, yield 37%).

<8-(4-甲氧基苯甲基氧基)-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(3a)之製造4> <8-(4-Methoxybenzyloxy)-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacyclo-5-one (3a) Manufacturing 4>

將8-(1,1-二甲基-3-側氧基丁基胺基)-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮(4b-1)(1.12g,2.51mmol)、1-甲基-2-四氫吡咯酮(10.0mL)與吡啶(0.20mL,2.49mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(0.47g,2.47mmol),以外溫50℃攪拌20小時20分鐘。將反應液放冷冷卻,加入醋酸乙酯(55.0mL)、水(55.0mL)進行萃取。以醋酸乙酯(10.0mL)萃取水層後,將有機層匯集,加入四氫呋喃(30.0mL),以水(55.0mL)洗淨2次,以4%碳酸氫鈉水 溶液(55.0mL)洗淨2次,濃縮有機層。在濃縮殘渣中加入氯仿(22.0mL),將固體過濾,以氯仿(10.0mL)洗淨後,濃縮濾液。將濃縮殘渣以二氧化矽凝膠管柱層析儀(氯仿)精製,接著以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得粗體的標記化合物(0.018g)。在粗體中加入甲苯-正庚烷(0.36mL),將固體過濾,以甲苯-正庚烷(0.54mL)洗淨,獲得標記化合物(0.010g,產率0.95%)。 8-(1,1-Dimethyl-3-oxobutylbutylamino)-3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one (4b-1) (1.12g, 2.51mmol), a mixture of 1-methyl-2-tetrahydropyrrolidone (10.0mL) and pyridine (0.20mL, 2.49mmol), stirred at room temperature, added p-toluene The acid monohydrate (0.47 g, 2.47 mmol) was stirred at an external temperature of 50 ° C for 20 hours and 20 minutes. The reaction solution was cooled and cooled, and ethyl acetate (55.0 mL) and water (55.0 mL) were added for extraction. After extracting the aqueous layer with ethyl acetate (10.0 mL), the organic layer was combined, then added to tetrahydrofuran (30.0 mL), and washed twice with water (55.0 mL) to 4% sodium bicarbonate water The solution (55.0 mL) was washed twice and the organic layer was concentrated. Chloroform (22.0 mL) was added to the residue, and the solid was filtered, washed with chloroform (10.0 mL), and the filtrate was concentrated. The concentrated residue was purified by a cerium chloride gel column chromatography (chloroform), and then purified by a silica gel column chromatography (ethyl acetate-hexane) to give a crude compound (0.018 g). ). Toluene-n-heptane (0.36 mL) was added to the residue, and the solid was filtered and washed with toluene-n-heptane (0.54mL) to give the title compound (0.010 g, yield: 0.95%).

<8-苯甲基氧基甲氧基-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(3b)之製造1> Manufacture of <8-benzyloxymethoxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacyclo-5-one (3b) 1>

將8-胺基-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮(8b)(1.00g,2.88mmol)、2,2-二甲氧基丙烷(19.4mL,158mmol)、吡啶(0.23mL,2.86mmol)與水(1.04mL,57.7mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(0.55g,2.89mmol),耐壓條件下,以外溫75℃攪拌138小時44分鐘。將反應液放冷冷卻、濃縮後,在殘渣中加 入醋酸乙酯(14.0mL)、四氫呋喃(10.0mL)、水(12.0mL)進行萃取。以醋酸乙酯(10.0mL)萃取水層後,將有機層匯集,以4%碳酸氫鈉水溶液(12.0mL)洗淨,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(氯仿)精製2次後,獲得粗體的標記化合物(0.43g)。在粗體中加入甲苯(2.10mL)、正庚烷(4.20mL),以外溫80℃攪拌30分鐘,以外溫4℃冷卻,攪拌19小時,過濾,以甲苯及正庚烷的混合溶劑(1:2,4.00mL)洗淨,獲得標記化合物(0.17g,產率14%)。 8-Amino-3-benzyloxymethoxybenzo[c]benzopyran-6-one (8b) (1.00 g, 2.88 mmol), 2,2-dimethoxypropane ( 19.4 mL, 158 mmol), a mixture of pyridine (0.23 mL, 2.86 mmol) and water (1.04 mL, 57.7 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (0.55 g, 2.89 mmol) was added. Under the conditions, the mixture was stirred at an external temperature of 75 ° C for 138 hours and 44 minutes. The reaction solution is cooled, concentrated, and added to the residue. Extraction was carried out by adding ethyl acetate (14.0 mL), tetrahydrofuran (10.0 mL), and water (12.0 mL). After extracting the aqueous layer with ethyl acetate (10.0 mL), the organic layer was collected, washed with 4% aqueous sodium hydrogen carbonate (12.0 mL), and the organic layer was concentrated. The concentrated residue was purified twice by a silica gel column chromatography (chloroform) to afford crude compound (0.43 g). Toluene (2.10 mL) and n-heptane (4.20 mL) were added to the crude mixture, and the mixture was stirred at an external temperature of 80 ° C for 30 minutes, cooled at an external temperature of 4 ° C, stirred for 19 hours, and filtered to obtain a mixed solvent of toluene and n-heptane (1). : 2, 4.00 mL) was washed to give the title compound (0.17 g, yield 14%).

<8-(1,1-二甲基-3-側氧基丁基胺基)-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮(4c)之製造> <8-(1,1-Dimethyl-3-oxobutylbutylamino)-3-benzyloxymethoxybenzo[c]benzopyran-6-one (4c) Manufacturing >

將8-胺基-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮(8b)(1.50g,4.32mmol)、2,2-二甲氧基丙烷(36.0mL,294mmol)、吡啶(0.43mL,5.35mmol)與水(1.94mL,108mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(1.03g,5.41mmol),在其懸浮液中加入1-甲基-2-四氫吡咯酮(10.0mL)溶解,攪拌67小時12分鐘。將反應液濃 縮,加入醋酸乙酯(30.0mL)、水(60.0mL)萃取。以醋酸乙酯(30.0mL)萃取水層後,將有機層匯集,加入醋酸乙酯(30.0mL)、水(60.0mL)萃取後,在有機層中以水(60.0mL)洗淨3次。濃縮有機層,將殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(0.78g,產率33%)。 8-Amino-3-benzyloxymethoxybenzo[c]benzopyran-6-one (8b) (1.50 g, 4.32 mmol), 2,2-dimethoxypropane ( 36.0 mL, 294 mmol), a mixture of pyridine (0.43 mL, 5.35 mmol) and water (1.94 mL, 108 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (1.03 g, 5.41 mmol) was added and suspended. The solution was dissolved in 1-methyl-2-tetrahydropyrrolidone (10.0 mL) and stirred for 67 hours and 12 minutes. Concentrate the reaction solution The mixture was extracted with ethyl acetate (30.0 mL) and water (60.0 mL). After extracting the aqueous layer with ethyl acetate (30.0 mL), the organic layer was combined, and ethyl acetate (30.0 mL) and water (60.0 mL) were added to extract, and the organic layer was washed three times with water (60.0 mL). The organic layer was concentrated, and the residue was purified to silica gel chromatography eluting

<8-苯甲基氧基甲氧基-2,2,4-三甲基-1,2-二氫-6-氧雜-1-氮雜屈-5-酮(3b)之製造2> Manufacture of <8-benzyloxymethoxy-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-azacyclo-5-one (3b) 2>

將8-(1,1-二甲基-3-側氧基丁基胺基)-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮(4c)(0.79g,1.77mmol)、1-甲基-2-四氫吡咯酮(16.0mL)與吡啶(0.15mL,1.87mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(0.36g,1.89mmol),以外溫50℃攪拌23小時53分鐘。將反應液放冷冷卻,加入醋酸乙酯(40.0mL)、水(40.0mL)進行萃取。以醋酸乙酯(8.0mL)萃取水層後,將有機層匯集,以水(40.0mL)洗淨2次,以4%碳酸氫鈉水溶液(40.0mL)洗淨2次,將 有機層濃縮。在濃縮殘渣中加入氯仿(16.0mL),將固體過濾,以氯仿(5.0mL)洗淨後,濃縮濾液。將濃縮殘渣以二氧化矽凝膠管柱層析儀(氯仿)精製,獲得標記化合物(0.0092g,產率1.15%)。 8-(1,1-Dimethyl-3-oxobutylbutylamino)-3-benzyloxymethoxybenzo[c]benzopyran-6-one (4c) ( 0.79 g, 1.77 mmol), a mixture of 1-methyl-2-tetrahydropyrrolidone (16.0 mL) and pyridine (0.15 mL, 1.87 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (0.36) was added. g, 1.89 mmol), stirred at an external temperature of 50 ° C for 23 hours and 53 minutes. The reaction solution was cooled and cooled, and ethyl acetate (40.0 mL) and water (40.0 mL) were added to extract. After extracting the aqueous layer with ethyl acetate (8.0 mL), the organic layer was combined, washed twice with water (40.0 mL), and washed twice with 4% aqueous sodium bicarbonate (40.0 mL). The organic layer was concentrated. Chloroform (16.0 mL) was added to the residue, and the solid was filtered, washed with chloroform (5.0 mL), and the filtrate was concentrated. The concentrated residue was purified by silica gel column chromatography (chloroform) to give the title compound (0.0092 g, yield: 1.15%).

<2-(2,4-二甲氧基苯基)-5-胺基苯甲酸甲酯(11a)之製造> Production of <2-(2,4-dimethoxyphenyl)-5-aminobenzoic acid methyl ester (11a) >

將2-(2,4-二甲氧基苯基)-5-硝基苯甲酸甲酯(4.00g,12.6mmol,國際公開2008/059865號小冊)、N,N-二甲基甲醯胺(46.0mL)、甲醇(12.0mL)與10%鈀碳(水份52.1%)(0.19g)的混合液以室溫攪拌,以氫氣3.0kgf/cm2的條件下攪拌4小時25分鐘。將反應液矽藻土過濾,以甲醇、水(100.0mL)洗淨。在濾液中加入醋酸乙酯(200.0mL)、水(100.0mL)進行萃取。以醋酸乙酯(100.0mL)萃取水層2次,將有機層匯集,以5%氯化鈉水溶液(200.0mL)洗淨6次,以無水硫酸鎂乾燥有機層後,使其濃縮。將濃縮殘渣以二氧化矽凝膠管柱層析儀(氯仿-甲醇)精製2次,獲得標記化合物(2.60g,產率72%)。 Methyl 2-(2,4-dimethoxyphenyl)-5-nitrobenzoate (4.00 g, 12.6 mmol, International Publication No. 2008/059865), N,N-dimethylformamidine A mixture of an amine (46.0 mL), methanol (12.0 mL) and 10% palladium carbon (52.1%) (0.19 g) was stirred at room temperature, and stirred under a condition of 3.0 kgf/cm 2 of hydrogen for 4 hours and 25 minutes. The reaction solution was filtered over Celite, and washed with methanol and water (100.0 mL). Ethyl acetate (200.0 mL) and water (100.0 mL) were added to the filtrate for extraction. The aqueous layer was extracted twice with ethyl acetate (100.0 mL), and the organic layer was combined and washed twice with 5% aqueous sodium chloride (200.0 mL). The concentrated residue was purified twice with a silica gel column chromatography (chloroform-methanol) to give the title compound (2.60 g, yield 72%).

<6-(2,4-甲氧基)-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯(12a)之製造> Manufacture of <6-(2,4-methoxy)-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid methyl ester (12a) >

將2-(2,4-二甲氧基苯基)-5-胺基苯甲酸甲酯(11a)(2.64g,9.19mmol)、2,2-二甲氧基丙烷(60.0mL,490mmol)、吡啶(0.73mL,9.08mmol)與水(3.20mL,178mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(1.72g,9.04mmol),以外溫105℃攪拌72小時。以過濾去除反應液中的不溶物,濃縮濾液。在濃縮殘渣中加入醋酸乙酯(26.0mL)、水(26.0mL)進行萃取。以醋酸乙酯(13.0mL)萃取水層2次,將有機層匯集,以4%氯化鈉水溶液(50.0mL)洗淨有機層2次,以無水硫酸鎂乾燥後,使其濃縮。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(0.27g,產率8.1%)。 Methyl 2-(2,4-dimethoxyphenyl)-5-aminobenzoate (11a) (2.64 g, 9.19 mmol), 2,2-dimethoxypropane (60.0 mL, 490 mmol) A mixture of pyridine (0.73 mL, 9.08 mmol) and water (3.20 mL, 178 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (1.72 g, 9.04 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C for 72 hours. The insoluble matter in the reaction liquid was removed by filtration, and the filtrate was concentrated. Ethyl acetate (26.0 mL) and water (26.0 mL) were added to the residue to extract. The aqueous layer was extracted twice with ethyl acetate (13.0 mL), and the organic layer was combined, and the organic layer was washed twice with 4% aqueous sodium chloride (50.0 mL) and dried over anhydrous magnesium sulfate. The residue was purified by silica gel chromatography (ethyl acetate-hexane) to give the title compound (0.27 g, yield 8.1%).

<6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸(14a)及6-溴-2,2,4-三甲基-1,2-二氫喹啉-7-羧酸的異構體混合物之製造> <6-Bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2- Manufacture of isomer mixtures of dihydroquinoline-7-carboxylic acid >

將5-胺基-2-溴苯甲酸(13a)(5.00g,23.1mmol)、2,2-二甲氧基丙烷(156mL,1273mmol)、吡啶(1.86mL,23.1mmol)與水(8.40mL,466mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(4.40g,23.1mmol),以外溫100℃攪拌48小時。濃縮反應液,將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製3次,接著以二氧化矽凝膠管柱層析儀(氯仿-甲醇)精製2次,獲得標記的異構體混合物(1.26g,產率18%)。 5-Amino-2-bromobenzoic acid (13a) (5.00 g, 23.1 mmol), 2,2-dimethoxypropane (156 mL, 1273 mmol), pyridine (1.86 mL, 23.1 mmol) and water (8.40 mL) The mixture of 466 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (4.40 g, 23.1 mmol) was added, and the mixture was stirred at an external temperature of 100 ° C for 48 hours. The reaction mixture was concentrated, and the residue was purified by EtOAc (EtOAc) eluting with EtOAc (EtOAc) , a mixture of labeled isomers (1.26 g, yield 18%) was obtained.

<6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸(14a)之製造> <Manufacture of <6-bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid (14a)>

將6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸(14a)及6-溴-2,2,4-三甲基-1,2-二氫喹啉-7-羧酸的異構體混合物(1.00g,3.38mmol)與低水份溶劑甲醇(80.0mL)之混合液以外溫4℃攪拌,加入亞硫醯氯(2.30mL,31.7mmol)攪拌73小時10分鐘。濃縮反應液,加入醋酸乙酯(80.0mL)、4%碳酸氫鈉水溶液(180.0mL)進行萃取。以醋酸乙酯(50.0mL)萃取水層後,將有機層匯集,以4%碳酸氫鈉水溶液(100.0mL)洗淨2次,濃縮有機層,獲得異構體化合物。將水層匯集,加入濃鹽酸(14.7mL),以醋酸乙酯(400.0mL)萃取,藉由濃縮而獲得殘留異構體的標記化合物(0.56g)。將上述的操作反復3次後,獲得標記化合物(0.26g,產率25%)。 6-Bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid (14a) and 6-bromo-2,2,4-trimethyl-1,2- A mixture of the isomer mixture of dihydroquinoline-7-carboxylic acid (1.00 g, 3.38 mmol) and a low water solvent methanol (80.0 mL) was stirred at an external temperature of 4 ° C, and sulphur chloride (2.30 mL, 31.7) was added. Methyl) was stirred for 73 hours and 10 minutes. The reaction solution was concentrated, and ethyl acetate (80.0 mL) and 4% aqueous sodium hydrogen carbonate (180.0 mL) was added to extract. After extracting the aqueous layer with ethyl acetate (50.0 mL), the organic layer was combined, washed twice with 4% aqueous sodium hydrogen carbonate (100.0 mL), and the organic layer was concentrated to give an isomer compound. The aqueous layer was combined, and concentrated hydrochloric acid (14.7 mL) was added, and ethyl acetate (400.0 mL) was evaporated. After repeating the above operation three times, a labeled compound (0.26 g, yield 25%) was obtained.

<6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯(15a)之製造> <Manufacture of <6-bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid methyl ester (15a)>

將6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸(14a)(0.24g,0.81mmol)與低水份溶劑甲醇(20.0mL)的混合液以冰冷攪拌,加入亞硫醯氯(18.6mL,257mmol),迴流攪拌42小時50分鐘。將反應液放冷冷卻、濃縮後,加入醋酸乙酯(20.0mL)、4%碳酸氫鈉水溶液(20.0mL)進行萃取,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(0.021g,產率8.6%)。 Mixture of 6-bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid (14a) (0.24 g, 0.81 mmol) with low water solvent methanol (20.0 mL) The solution was stirred with ice cold, sulphur chloride (18.6 mL, 257 mmol). The reaction mixture was cooled and cooled and concentrated. ethyl acetate (20.0 mL) and 4% aqueous sodium hydrogencarbonate (20.0 mL) was added to extract and the organic layer was concentrated. The residue was purified by silica gel chromatography (ethyl acetate-hexane) to give the title compound (0.021 g, yield 8.6%).

<6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯(15a)及6-溴 -2,2,4-三甲基-1,2-二氫喹啉-7-羧酸甲酯的異構體混合物之製造> <6-Bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid methyl ester (15a) and 6-bromo Manufacture of an isomer mixture of -2,2,4-trimethyl-1,2-dihydroquinoline-7-carboxylic acid methyl ester >

將2-溴-5-胺基苯甲酸甲酯(16a)(4.00g,17.4mmol)、2,2-二甲氧基丙烷(120mL,979mmol)、吡啶(1.40mL,17.4mmol)與水(6.30mL,350mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(3.32g,17.5mmol),耐壓條件下,以外溫105℃攪拌65小時30分鐘。將反應液放冷冷卻、濃縮,加入醋酸乙酯(80.0mL)、水(80.0mL)進行萃取。將有機層以水(80.0mL)洗淨,以4%碳酸氫鈉水溶液(80.0mL)洗淨,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製3次,接著以二氧化矽凝膠管柱層析儀(氯仿)精製2次,獲得標記的異構體混合物(1.50g,產率28%)。 Methyl 2-bromo-5-aminobenzoate (16a) (4.00 g, 17.4 mmol), 2,2-dimethoxypropane (120 mL, 979 mmol), pyridine (1.40 mL, 17.4 mmol) and water ( The mixture of 6.30 mL, 350 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (3.32 g, 17.5 mmol) was added, and the mixture was stirred at an external temperature of 105 ° C for 65 hours and 30 minutes under pressure. The reaction solution was cooled, cooled and concentrated, and ethyl acetate (80.0 mL) and water (80.0 mL) were added for extraction. The organic layer was washed with water (80.0 mL) and washed with 4% aqueous sodium hydrogen carbonate (80.0 mL). The concentrated residue was purified by a cerium oxide gel column chromatography (ethyl acetate-hexane) three times, and then purified twice with a cerium oxide gel column chromatography (chloroform) to obtain a labeled isomer. Bulk mixture (1.50 g, yield 28%).

<2-溴-5-(1,1-二甲基-3-側氧基丁基胺基)苯甲酸甲酯(17) 之製造> <2-Bromo-5-(1,1-dimethyl-3-oxobutylbutylamino)benzoic acid methyl ester (17) Manufacturing >

將2-溴-5-胺基苯甲酸甲酯(16a)(4.00g,17.4mmol)、2,2-二甲氧基丙烷(120mL,979mmol)、吡啶(1.40mL,17.4mmol)與水(6.30mL,350mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(3.31g,17.4mmol)攪拌71小時18分鐘。濃縮反應液,加入醋酸乙酯(80.0mL)、水(80.0mL)進行萃取。以醋酸乙酯萃取水層2次後,將有機層匯集,以4%碳酸氫鈉水溶液(80.0mL)洗淨,濃縮有機層。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製3次,獲得標記化合物(1.29g,產率23%)。 Methyl 2-bromo-5-aminobenzoate (16a) (4.00 g, 17.4 mmol), 2,2-dimethoxypropane (120 mL, 979 mmol), pyridine (1.40 mL, 17.4 mmol) and water ( The mixture of 6.30 mL, 350 mmol) was stirred at room temperature, and p-toluenesulfonic acid monohydrate (3.31 g, 17.4 mmol) was added and stirred for 71 hours and 18 minutes. The reaction solution was concentrated, and ethyl acetate (80.0 mL) and water (80.0 mL) were added to extract. After the aqueous layer was extracted twice with ethyl acetate, the organic layer was combined, washed with 4% aqueous sodium hydrogen carbonate (80.0 mL), and the organic layer was concentrated. The concentrated residue was purified 3 times with EtOAc (EtOAc-hexane) to afford titled compound ( 1.29 g, yield 23%).

<6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯(15a)之製造> <Manufacture of <6-bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylic acid methyl ester (15a)>

將2-溴-5-(1,1-二甲基-3-側氧基丁基胺基)苯甲酸甲酯(17)(1.00g,3.05mmol)、低水份溶劑甲醇(10.0mL)、吡啶(0.25mL,3.11 mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(0.57g,3.00mmol),以外溫50℃攪拌17小時15分鐘。將反應液室溫放冷、濃縮後,加入醋酸乙酯(15.0mL)、水(10.0mL)進行萃取。以4%碳酸氫鈉水溶液(10.0mL)萃取有機層後,濃縮有機層濃縮。將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(0.0095g,產率1.00%)。 Methyl 2-bromo-5-(1,1-dimethyl-3-oxobutylbutyl)benzoate (17) (1.00 g, 3.05 mmol), methanol in low water (10.0 mL) , pyridine (0.25mL, 3.11 The mixture of mmol) was stirred at room temperature, p-toluenesulfonic acid monohydrate (0.57 g, 3.00 mmol) was added, and the mixture was stirred at an external temperature of 50 ° C for 17 hours and 15 minutes. The reaction solution was allowed to cool at room temperature and concentrated, and then ethyl acetate (15.0 mL) and water (10.0 mL) were added to extract. The organic layer was extracted with a 4% aqueous sodium hydrogen sulfate solution (10.0 mL), and evaporated. The concentrated residue was purified by silica gel chromatography (ethyl acetate-hexane) to give the title compound (0.0095 g, yield 1.00%).

<2,2,4-三甲基-1,2-二氫喹啉(7a)之製造> <Manufacture of <2,2,4-trimethyl-1,2-dihydroquinoline (7a)>

將苯胺(6a)(0.980mL,10.7mmol)、2,2-二甲氧基丙烷(66mL,537mmol)、吡啶(0.860mL,10.7mmol)與水(3.90mL,216mmol)的混合液以室溫攪拌,加入對-甲苯磺酸一水合物(2.04g,10.7mmol),以外溫50℃攪拌22小時。將反應液濃縮,將濃縮殘渣以二氧化矽凝膠管柱層析儀(醋酸乙酯-己烷)精製,獲得標記化合物(1.18g,產率63.2%)。 A mixture of aniline (6a) (0.980 mL, 10.7 mmol), 2,2-dimethoxypropane (66 mL, 537 mmol), pyridine (0.860 mL, 10.7 mmol) and water (3.90 mL, 216 mmol) After stirring, p-toluenesulfonic acid monohydrate (2.04 g, 10.7 mmol) was added, and the mixture was stirred at an external temperature of 50 ° C for 22 hours. The reaction mixture was concentrated, and the residue was evaporated to mjjjjjjjj

[產業上應用的可能性] [Possibility of application in industry]

依照本發明,可使用於工業上製造具有糖皮質激素受容體結合活性的1,2-二氫喹啉衍生物之合成中間體。同時,此等中間體可使用於有關糖皮質激素受容體的疾病之預防或治療,即可使用於糖尿病、肥胖症等代謝異常疾病、腸炎、慢性閉塞性肺病等炎症性疾病、類風濕性關節炎、膠原病等自體免疫疾病、哮喘、異位性皮膚炎、過敏性鼻炎等過敏性疾病、精神病、阿爾茲海默氏症、藥物使用障礙等中樞神經系疾病、高血壓、高鈣血症、高胰島素血症、高脂血症等心血管系疾病、神經‧免疫‧內分泌的平衡異常造成之動態平衡相關疾病、青光眼等的預防或治療。 According to the present invention, it is possible to industrially produce a synthetic intermediate of a 1,2-dihydroquinoline derivative having a glucocorticoid receptor-binding activity. At the same time, these intermediates can be used for the prevention or treatment of diseases related to glucocorticoid receptors, and can be used for inflammatory diseases such as diabetes, obesity and other metabolic abnormal diseases, enteritis, chronic obstructive pulmonary diseases, and rheumatoid joints. Autoimmune diseases such as inflammation and collagen diseases, asthma, atopic dermatitis, allergic rhinitis and other allergic diseases, psychosis, Alzheimer's disease, drug use disorders and other central nervous system diseases, hypertension, hypercalcemia Prevention, treatment of cardiovascular diseases such as hyperinsulinemia, hyperinsulinemia, and hyperlipidemia, and dynamic balance-related diseases caused by abnormal balance of nerves, immunity, and endocrine, and glaucoma.

Claims (9)

一種式(2)表示的化合物或其鹽之製造方法, 其特徵係使式(1)表示的化合物或其鹽在 (A)選自對-甲苯磺酸、對-甲苯磺酸吡啶鎓、溴化氫酸及吡啶溴化氫酸鹽所形成之群組中的酸及/或(B)選自吡啶及N,N-二甲基苯胺所形成之群組中的鹼、及(C)水的存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應。 A method for producing a compound represented by the formula (2) or a salt thereof, Characterized by the compound represented by the formula (1) or a salt thereof (A) an acid selected from the group consisting of p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrogen bromide and pyridine hydrobromide and/or (B) selected from the group consisting of pyridine and N, The base in the group formed by N-dimethylaniline and (C) water are reacted with 2,2-dialkoxypropane or isopropenyl alkyl ether. 一種式(3)表示的化合物或其鹽之製造方法, [式(3)中,R0表示對-甲氧基苯甲基或苯甲基氧基甲基],其特徵係藉由申請專利範圍第1項所述之方法,獲得式(2)表示的化合物或其鹽,接著使該式(2)表示的化合物或其鹽在 選自酸及鹼所形成之群組中的至少一種之存在下,與式(a)R0X表示的化合物或其鹽反應[式中,R0表示對-甲氧基苯甲基或苯甲基氧基甲基,X表示脫離基]。 A method for producing a compound represented by the formula (3) or a salt thereof, [In the formula (3), R 0 represents p-methoxybenzyl or benzyloxymethyl], which is characterized by the method of the first aspect of the patent application, wherein the formula (2) is obtained. a compound or a salt thereof, and then a compound represented by the formula (2) or a salt thereof, in the presence of at least one selected from the group consisting of an acid and a base, and a compound represented by the formula (a) R 0 X or Its salt reaction [wherein, R 0 represents p-methoxybenzyl or benzyloxymethyl, and X represents a cleavable group]. 如申請專利範圍第1或2項所述之製造方法,其中,由申請專利範圍第1項所述之式(1)表示的化合物或其鹽製造式(2)表示的化合物或其鹽之反應,介入反應中途生成的式(4)表示之化合物或其鹽而進行。 The production method according to the first or second aspect of the invention, wherein the compound represented by the formula (1) described in the first aspect of the patent application or the salt thereof is used for producing a compound represented by the formula (2) or a salt thereof. The compound represented by the formula (4) or a salt thereof formed in the middle of the reaction is carried out. 如申請專利範圍第1至3項中任一項所述之製造方法,其中,式(1)表示的化合物或其鹽為使式(5)表示的化合物或其鹽與對-甲苯磺酸、鹽酸或溴酸反應所製造。 The production method according to any one of the above aspects, wherein the compound represented by the formula (1) or a salt thereof is a compound represented by the formula (5) or a salt thereof and p-toluenesulfonic acid, Manufactured by the reaction of hydrochloric acid or bromic acid. 如申請專利範圍第1至4項中任一項所述之製造方法,其中,式(1)表示的化合物之鹽為式(1)表示的化合物之對-甲苯磺酸鹽、鹽酸鹽或溴酸鹽。 The production method according to any one of claims 1 to 4, wherein the salt of the compound represented by the formula (1) is a p-toluenesulfonate or a hydrochloride of the compound represented by the formula (1) or Bromate. 一種式(7)表示的化合物或其鹽之製造方法, [式中,R1表示鹵素原子、低級烷基、羥基、低級烷氧基、低級烷基羰基、羧基、胺基、硝基或氰基;p表示0至4的整數],其中,使式(6)表示的化合物或其鹽在 [式中,R1表示鹵素原子、低級烷基、羥基、低級烷氧基、低級烷基羰基、羧基、胺基、硝基或氰基;p表示0至4的整數](A)選自對-甲苯磺酸、對-甲苯磺酸吡啶鎓、溴化氫酸及吡啶溴化氫酸鹽所形成之群組中的酸及/或(B)選自吡啶及N,N-二甲基苯胺所形成之群組中的鹼、及(C)水的存在下,與2,2-二烷氧基丙烷或異丙烯基烷基醚反應。 A method for producing a compound represented by the formula (7) or a salt thereof, Wherein R 1 represents a halogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amine group, a nitro group or a cyano group; p represents an integer of 0 to 4, wherein The compound represented by (6) or a salt thereof is [wherein, R 1 represents a halogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a lower alkylcarbonyl group, a carboxyl group, an amine group, a nitro group or a cyano group; p represents an integer of 0 to 4] (A) is selected from the group consisting of The acid in the group formed by p-toluenesulfonic acid, pyridinium p-toluenesulfonate, hydrogen bromide and pyridine hydrobromide and/or (B) is selected from the group consisting of pyridine and N,N-dimethyl The reaction with a 2,2-dialkoxypropane or an isopropenylalkyl ether in the presence of a base in the group formed by aniline and (C) water. 如申請專利範圍第1至6項中任一項所述之製造方法,其中,2,2-二烷氧基丙烷為2,2-二甲氧基丙烷。 The production method according to any one of claims 1 to 6, wherein the 2,2-dialkoxypropane is 2,2-dimethoxypropane. 如申請專利範圍第1至6項中任一項所述之製造方法,其中,異丙烯基烷基醚為異丙烯基甲基醚。 The production method according to any one of claims 1 to 6, wherein the isopropenylalkyl ether is isopropenylmethyl ether. 一種化合物及其鹽,其係選自‧8-胺基-3-羥基苯并[c]苯并吡喃-6-酮的對-甲苯磺酸鹽、‧8-(1,1-二甲基-3-側氧基丁基胺基)-3-羥基苯并[c]苯并吡喃-6-酮、 ‧8-胺基-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮、‧8-胺基-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮、‧8-(1,1-二甲基-3-側氧基丁基胺基)-3-(4-甲氧基苯甲基氧基)苯并[c]苯并吡喃-6-酮、‧8-(1,1-二甲基-3-側氧基丁基胺基)-3-苯甲基氧基甲氧基苯并[c]苯并吡喃-6-酮、‧2-(2,4-二甲氧基苯基)-5-胺基苯甲酸甲酯、‧6-(2,4-甲氧基)-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯、‧6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸、‧6-溴-2,2,4-三甲基-1,2-二氫喹啉-5-羧酸甲酯、‧2-溴-5-(1,1-二甲基-3-側氧基丁基胺基)苯甲酸甲酯。 a compound and a salt thereof selected from p-toluenesulfonate of ‧8-amino-3-hydroxybenzo[c]benzopyran-6-one, ‧8-(1,1-dimethyl 3-yloxybutylamino)-3-hydroxybenzo[c]benzopyran-6-one, ‧8-Amino-3-(4-methoxybenzyloxy)benzo[c]benzopyran-6-one, ‧8-amino-3-benzyloxymethoxy Benzo[c]benzopyran-6-one, ‧8-(1,1-dimethyl-3-oxobutylbutylamino)-3-(4-methoxybenzyloxy) Benzo[c]benzopyran-6-one, ‧8-(1,1-dimethyl-3-oxobutylbutylamino)-3-benzyloxymethoxybenzo [c] benzopyran-6-one, methyl ‧2-(2,4-dimethoxyphenyl)-5-aminobenzoate, ‧6-(2,4-methoxy)- Methyl 2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylate, ‧6-bromo-2,2,4-trimethyl-1,2-dihydroquinoline 5-carboxylic acid, methyl ‧6-bromo-2,2,4-trimethyl-1,2-dihydroquinolin-5-carboxylate, ‧2-bromo-5-(1,1-dimethyl Methyl-3-oxobutylbutylamino)benzoate.
TW102147141A 2012-12-20 2013-12-19 Method for production of 1,2-dihydroquinoline synthetic intermediate TW201431860A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012278428 2012-12-20

Publications (1)

Publication Number Publication Date
TW201431860A true TW201431860A (en) 2014-08-16

Family

ID=50978374

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102147141A TW201431860A (en) 2012-12-20 2013-12-19 Method for production of 1,2-dihydroquinoline synthetic intermediate

Country Status (3)

Country Link
JP (1) JP2014139161A (en)
TW (1) TW201431860A (en)
WO (1) WO2014098046A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3639854A4 (en) 2017-06-16 2021-03-03 The Doshisha Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
WO2018230713A1 (en) 2017-06-16 2018-12-20 学校法人同志社 Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090086070A (en) * 2006-11-14 2009-08-10 산텐 세이야꾸 가부시키가이샤 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
KR20140117481A (en) * 2012-01-20 2014-10-07 산텐 세이야꾸 가부시키가이샤 Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof

Also Published As

Publication number Publication date
WO2014098046A1 (en) 2014-06-26
JP2014139161A (en) 2014-07-31

Similar Documents

Publication Publication Date Title
AU2015282127B2 (en) Method for producing fused heterocyclic compound
CN103562194A (en) Method for synthesizing ketobenzofuran derivatives
JP4828863B2 (en) Process for producing (Z) -1-phenyl-1- (N, N-diethylaminocarbonyl) -2-phthalimidomethylcyclopropane
TW201431860A (en) Method for production of 1,2-dihydroquinoline synthetic intermediate
EP2102161B1 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl- 2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide
WO2013108921A1 (en) Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof
JP2001508452A (en) Method for producing thiazole derivative
WO2015020204A1 (en) Production method for 3, 3-dimethyl-3, 4-dihydro-1h-quinoxaline-2-one derivative and intermediate for said production method
JP4026233B2 (en) Method for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine
WO2016095662A1 (en) Method for preparing (2s,3r,4r)-3,5-disubstituted-2-deoxy-2-hydroxy-2-methyl-d-ribose-γ-lactone and intermediate thereof
JPH0597840A (en) Production of 3-acylamino-6-phenyloxy-7-alkyl sulfonylamino-4h-1-benzopyran-4-one or its salt
KR101041277B1 (en) Process for producing quinolonecarboxylic acid derivative
JP3533567B2 (en) A new synthetic method to produce substituted quinolines from substituted anilines
JP4061333B2 (en) 2- (Pyrazol-1-yl) pyridine derivatives
JP2018062513A (en) Method for producing sulfonamide compound
TW201722963A (en) Novel process for preparing thienopyrimidine compound and intermediates used therein
JP4398636B2 (en) Process for producing N- [3- (acylamino) -4-oxo-6-phenoxy-4H-chromen-7-yl] alkylsulfonamide derivatives or salts thereof and intermediates thereof
JP4552939B2 (en) 2-substituted-3- (4-tetrahydropyranyl) -3-oxopropanoic acid ester and process for producing the same
TW202229290A (en) Method for producing octahydrothienoquinoline compound, and production intermediate thereof
JP4449211B2 (en) 6- (1-fluoroethyl) -5-iodo-4-pyrimidone and process for producing the same
TW201718544A (en) Method for producing pyridinecarboxamide
US20120142932A1 (en) Method for manufacturing 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivative
KR20050108739A (en) Process for the preparation of (e)-2-benzoyl-3-dimethylaminoacrylate derivatives
WO2002046185A1 (en) Intermediates for synthesis of vinblastine compound and method of synthesizing the intermediates
WO2006025480A1 (en) 7-substituted carbostyril derivative and method for producing same